TWI376394B - Polyimide film - Google Patents

Polyimide film Download PDF

Info

Publication number
TWI376394B
TWI376394B TW96148315A TW96148315A TWI376394B TW I376394 B TWI376394 B TW I376394B TW 96148315 A TW96148315 A TW 96148315A TW 96148315 A TW96148315 A TW 96148315A TW I376394 B TWI376394 B TW I376394B
Authority
TW
Taiwan
Prior art keywords
film
bis
solution
fda
tda
Prior art date
Application number
TW96148315A
Other languages
Chinese (zh)
Other versions
TW200900431A (en
Inventor
Hak Gee Jung
Sang Wook Park
Hyo Jun Park
Original Assignee
Kolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020060128999A external-priority patent/KR101167339B1/en
Priority claimed from KR1020060129011A external-priority patent/KR101167483B1/en
Priority claimed from KR1020060128978A external-priority patent/KR101167337B1/en
Priority claimed from KR1020060129005A external-priority patent/KR101142692B1/en
Priority claimed from KR1020060128992A external-priority patent/KR101211857B1/en
Priority claimed from KR1020060129009A external-priority patent/KR101167341B1/en
Application filed by Kolon Inc filed Critical Kolon Inc
Publication of TW200900431A publication Critical patent/TW200900431A/en
Application granted granted Critical
Publication of TWI376394B publication Critical patent/TWI376394B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2379/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2361/00 - C08J2377/00
    • C08J2379/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08J2379/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Description

1376394 九、發明說明: 【發明所屬之技術領域】 本發明有關於一種無色且透明的聚亞酿胺膜。 【先前技術】 5 大體而言,聚亞醯胺(η)樹脂係與藉由聚醯胺酸在高溫 下之閉環及脫水反應所得的高耐熱樹脂有關,而聚醯胺酸 係透過芳香族二酸酐與芳香族二胺或芳香族二異氰酸酯的 溶液聚合反應所獲得。在聚亞醯胺樹脂的製備方面,芳香 族二酸酐包括例如:苯均四酸二酐(PMDA)或聯笨四酸二酐 10 (BPDA);以及芳香族二胺則包括例如:氧化二苯胺(〇DA)、 對-本二胺(p-PDA)、間-苯二胺(m_pDA)、亞曱基二苯胺 (MD A)及二胺基苯基六IL丙院(HFD A)。 因為不溶、難炼及超高耐熱性之聚亞酿胺樹脂具有包 括耐熱性與耐氧化性,耐輻射性,耐低溫性及耐化學性等 is優異的特性,所以被用於種種不同的領域,包括諸如汽車 材料、航空材料或航太材料之類的先進耐熱材料,與諸如 絕緣塗覆劑、絕緣膜、半導體、或TFT_LCD用電極保護膜 之類的電子材料。近來,聚亞醯胺樹脂已被用來作為顯示 器材料,例如將導電填料與聚合物混合,或將導電填料塗 20覆到聚合物薄臈表面上,所構成的光纖或液晶配向層,以 及透明電極膜。 然而,聚亞醯胺樹脂的高芳香環密度與電荷轉移交互 作用使其變成褐色或黃色,以致惱人地減低可見光範園的 透光率。聚亞醯胺樹脂的黃色或褐色使其難以應用於要求 6 1376394 透明度的領域中。 為解決這些問題,許多純化單體與高純度溶劑以進行 聚合的方法已被實現,但對透光率的改良效果卻不大。 美國專利第5053480號揭示一種使用脂環族二酸酐成 5分來取代芳香族二酸酐的方法。雖然此法與純化方法相 比,改善了液相或膜相的透明度與顏色,然而在增進透光 率方面仍然受限,因而無法達成高透光率的要求,另外, 其熱與機械性質也變差。 在美國專利第4595548號、4603061號、4645824號、 10 4895972 號、5218083 號、5093453 號、5218077 號 5367046 號、5338826號、5986036號與6232428號,以及韓國專利 公開第2003-0009437號中描述關於製備具新穎結構之聚亞 醯胺,係在熱性質未顯著降低的範圍内改善透光率與顏色 透明度,主要是使用具有諸如-〇-、-S〇2·或CH2·的連結基、 I5由於不在對位(P~P〇sition)連接而在間位(m-position)連接所 造成的彎折結構、或是具有如-CF3取代基之芳香族二酸酐 和芳香族二胺單體。然而,此種聚亞醯胺被證實其機械性 質、黃色指數與可見光透光率方面,均不足以用於半導體 絕緣膜、TFT-LCD絕緣膜、電極護膜及軟性顯示器基板。 20 【發明内容】 因此,本發明提供一種無色透明且展現出包括機械性 質及熱穩定性等優異性質的聚亞醯胺膜。 依據本發明的較佳實施例,係提供一種以芳香族二酸 7 13763941376394 IX. Description of the Invention: [Technical Field of the Invention] The present invention relates to a colorless and transparent polyalkylene amine film. [Prior Art] 5 In general, polyiminamide (η) resin is related to high heat resistant resin obtained by ring closure and dehydration reaction of polylysine at high temperature, and polyamine acid is transmitted through aromatic The acid anhydride is obtained by solution polymerization of an aromatic diamine or an aromatic diisocyanate. In the preparation of the polyamidamide resin, the aromatic dianhydride includes, for example, pyromellitic dianhydride (PMDA) or bismuth diacid dianhydride 10 (BPDA); and the aromatic diamine includes, for example, diphenylamine oxide. (〇DA), p-PDA (p-PDA), m-phenylenediamine (m_pDA), decylene diphenylamine (MD A), and diaminophenyl hexa-propyl acetate (HFD A). It is used in various fields because it has excellent properties such as heat resistance, oxidation resistance, radiation resistance, low temperature resistance and chemical resistance because it is insoluble, difficult to refine, and has high heat resistance. It includes advanced heat-resistant materials such as automotive materials, aerospace materials or aerospace materials, and electronic materials such as insulating coating agents, insulating films, semiconductors, or electrode protective films for TFT_LCD. Recently, polyamidamide resins have been used as display materials, such as mixing conductive fillers with polymers, or coating conductive coatings on the surface of polymer matte, forming optical fibers or liquid crystal alignment layers, and being transparent. Electrode film. However, the high aromatic ring density of the polyamidene resin interacts with charge transfer to cause it to become brown or yellow, so as to annoyingly reduce the light transmittance of the visible light. The yellow or brown color of the polyamide resin makes it difficult to apply in the field requiring transparency of 6 1376394. In order to solve these problems, many methods for purifying monomers and high-purity solvents for polymerization have been realized, but the improvement effect on light transmittance is not large. U.S. Patent No. 5,053,480 discloses a process for replacing an aromatic dianhydride with an alicyclic dianhydride in five parts. Although this method improves the transparency and color of the liquid phase or the film phase compared with the purification method, it is still limited in terms of improving the light transmittance, and thus the high light transmittance cannot be achieved, and the thermal and mechanical properties thereof are also Getting worse. The preparations are described in U.S. Patent Nos. 4,595,548, 4, 601, 036, 4, 458, 024, s, 4, 4, 895, 972, 5, 218, 083, 5, 093, 453, 5, 218, 017, 5, 367, 046, 5, 338, 826, 5, 968, 626, and 6, 232, 284, and in Korean Patent Publication No. 2003-0009437. Polyimide with a novel structure improves light transmittance and color transparency in a range where thermal properties are not significantly lowered, mainly using a linking group having, for example, -〇-, -S〇2· or CH2·, I5 A bent structure caused by a m-position connection without a p~P〇sition connection, or an aromatic dianhydride and an aromatic diamine monomer having a substituent such as a -CF3. However, such polyamines have been found to be insufficient for use in semiconductor insulating films, TFT-LCD insulating films, electrode films, and flexible display substrates in terms of mechanical properties, yellowness index, and visible light transmittance. 20 SUMMARY OF THE INVENTION Accordingly, the present invention provides a polyimide film which is colorless and transparent and exhibits excellent properties including mechanical properties and thermal stability. According to a preferred embodiment of the present invention, there is provided an aromatic diacid 7 1376394

、方t胺之聚合物所製成的聚亞酿胺膜,以5。至 100叫的膜厚為基準,使用紫外光分光光度計測量复 率’ ^波長380至· nm時,具有等於或大於㈣的平均 透光率’並具有等於或小於15的黃色指數。 - ίο 依據此實施例之聚亞醯胺膜,以5〇至1〇〇叫的膜厚 為基準,使用.紫外光分光光度計測量其透絲,於波長如 至780 rnn時,可具有等於或大於88%的平均透光率,於波 長550 nm時,可具有等於或大於88%的透光率,於波長5〇〇 nm時,可具有等於或大於85%的透光率,以及於波長42〇 nm時,可具有等於或大於50%的透光率。 依據此實施例之聚亞醯胺膜’以5〇至1〇〇 μιη的膜厚 為基準,於波長420 nm時,可具有小於50的光學密度。 在依據此實施例的聚亞醯胺膜中,芳香族二酸肝可包 含一種化合物,或是二種或多種化合物的混合物,該化合 15物係選自2,2-雙(3,4-二羧基苯基)六氟丙烷二酸酐 (2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride, 6-FDA)、4- (2,5-二氧四氫吱喃-3-基)-1,2,3,4-四氫化萘 -1,2-二缓酸酐(4-(2,5-dioxotetrahydrofuran-3-yl)-l,2,3,4-tetrahydronaphthalene-l,2-dicarboxylic anhydride, TDA)以及 2〇 4,4’- (4,4’_異丙烯基二苯氧基)雙(鄰苯二曱酸酐) (4,45-(4,45-isopropylidenediphenoxy)bis(phthalic anhydride), HBDA)。 在依據此實施例的聚亞醯胺膜中,芳香族二胺可包含 一種化合物,或是二種或多種化合物的混合物,該化合物 8 1376394 係選自氧化二苯胺(oxydianiline,ODA)、1,3-雙(3-胺基苯 氧基)苯(l,3-bis(3-aminophenoxy)benzene,APB-133)、1,3-雙(4-胺基苯氧基)苯(l,3-bis(4-aminophenoxy)benzene, APB-134) 、1,4-雙(4-胺基苯氧基)苯 5 (l,4-bis(4-aminophenoxy)benzene,APB-144)、雙(3-胺基笨 基)礙(bis(3-aminophenyl)sulfone,3-DDS)、雙(4-胺基苯 基)礙(bis(4-aminophenyl)sulfone,4-DDS)、2,2’-雙(三氟 曱基)-4,4’- 二胺基聯苯(2,2’-1^(出£111〇1*〇1116111>^)-4,4’-diaminobiphenyl,2,2’-TFDB)、3,3,-雙(三氟曱基)-4,4’-1〇 二胺基聯苯(3,3’-bis(trifluoromethyl)-4,4’-diaminobiphenyl, 3,3’-TFDB)、2,2’-雙[4 (4-胺基苯氧基)苯基]六氟丙烷 (2,2,-bis[4(4-aminophenoxy)phenyl]hexafluoropropane,4-BD AF)、2,2’-雙[3 (3-胺基苯氧基)苯基]六氟丙烷 (2,2,-bis[3(3-aminophenoxy)phenyl]hexafluoropropane,3-BD 15 AF)、4,4’-雙(3-胺基苯氧基)二苯基颯 (4,4,-bis(3-aminophenoxy)diphenylsulfone, DBSDA)以及 2,2-雙[4- (4-胺基苯氧基)苯基]丙烷 (2,2-bis[4-(4-aminophenoxy)phenyl]propane,6-HMDA)。 依據第三實施例之聚亞醯胺膜,以50至100 μιη的膜 20 厚為基準,於1 GHz時,可具有等於或小於3.0的介電常 數。 依據第三實施例之聚亞醯胺膜,以50至100 μιη的膜 厚為基準,於50至200°C時,可具有等於或小於50 ppm 的平均熱膨脹係數(CTE)。 9 依據第三實施例之聚亞醯胺膜,以50至100 μιη的膜 厚為基準,可具有等於或大於3.0 GPa的模數。 依據第三實施例之聚亞醯胺膜,以50至100 μιη的膜 厚為基準’可具有等於或小於400 nm之50%紫外光截止波 5 長(cut off wavelength)。 本發明可提供一種無色透明且具有包括機械性質及熱 穩定性等優異性質的聚亞醯胺樹脂,因而可供用於種種不 同的領域’包括半導體絕緣膜、TFT_LCD絕緣膜、鈍化膜、 液晶配向層、光學通訊材料、太陽能電池用保護膜以及軟 1〇性顯示器基板。本發明另亦提供一種使用該聚亞醯胺樹脂 的液晶配向層與聚亞醯胺膜。 【圖式簡單說明】 第一圖係為範例1之聚亞醯胺膜置於一張紙上的照 15片;以及 第二圖係為比較範例1之聚亞酿胺膜置於一張紙上的 照片。 【實施方式】 * 茲將本發明詳予說明於後。 本發明的聚亞醯胺膜是一種由二胺與二酸酐之共聚物 所製備之聚亞酿胺樹脂的薄膜,特別是一種無色透明的聚 亞醯胺膜。 本發明所製得之聚亞醯胺膜,以50至100 μιη的膜厚 10 1376394 為基準,使时外光分絲輯測量其透光率, 至 nm時,具有等於或大於85%的平均透光率,並長且^ 等於或小於15的黃色指數。A poly-branched amine film made of a polymer of a t-amine, which is 5. On the basis of the film thickness of 100 Å, the ultraviolet light spectrophotometer was used to measure the complex ' at a wavelength of 380 to · nm, and had an average transmittance equal to or greater than (4) and a yellow index equal to or less than 15. - ίο The polyimide film according to this embodiment is measured by a UV spectrophotometer based on a film thickness of 5 〇 to 1 〇〇, and may have a wavelength equal to a wavelength of 780 rnn. Or an average light transmittance of more than 88%, which may have a light transmittance equal to or greater than 88% at a wavelength of 550 nm, and a light transmittance equal to or greater than 85% at a wavelength of 5 〇〇 nm, and When the wavelength is 42 〇 nm, it may have a light transmittance equal to or greater than 50%. The polyimide film according to this embodiment may have an optical density of less than 50 at a wavelength of 420 nm based on a film thickness of 5 Å to 1 Å μη. In the polyimine membrane according to this embodiment, the aromatic diacid liver may comprise a compound or a mixture of two or more compounds selected from the group consisting of 2,2-bis (3,4- Dicarboxyphenyl) hexafluoropropane dianhydride (6-FDA), 4-(2,5-dioxotetrahydrofuran-3-yl)- 1,2,3,4-tetrahydronaphthalene-1,2- bis-acid anhydride (4-(2,5-dioxotetrahydrofuran-3-yl)-l,2,3,4-tetrahydronaphthalene-l,2-dicarboxylic anhydride , TDA) and 2〇4,4'-(4,4'-isopropenyldiphenoxy)bis(phthalic anhydride) (4,45-(4,45-isopropylidenediphenoxy)bis(phthalic anhydride) , HBDA). In the polyamidamine film according to this embodiment, the aromatic diamine may comprise a compound or a mixture of two or more compounds selected from the group consisting of oxydianiline (ODA), 1, 3-bis(3-aminophenoxy)benzene (APB-133), 1,3-bis(4-aminophenoxy)benzene (1,3) -bis(4-aminophenoxy)benzene, APB-134), 1,4-bis(4-aminophenoxy)benzene 5 (l,4-bis(4-aminophenoxy)benzene, APB-144), double ( Bis (3-aminophenyl)sulfone, 3-DDS, bis(4-aminophenyl)sulfone, 4-DDS, 2,2' - bis(trifluoromethyl)-4,4'-diaminobiphenyl (2,2'-1^(£111〇1*〇1116111>^)-4,4'-diaminobiphenyl,2,2 '-TFDB), 3,3,-bis(trifluoromethyl)-4,4'-1〇diaminobiphenyl (3,3'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 3, 3'-TFDB), 2,2'-bis[4 (4-aminophenoxy)phenyl]hexafluoropropane (2,2,-bis[4(4-aminophenoxy)phenyl]hexafluoropropane, 4-BD AF), 2,2'-bis[3 (3-aminophenoxy) Phenyl]hexafluoropropane (2,2,-bis[3(3-aminophenoxy)phenyl]hexafluoropropane, 3-BD 15 AF), 4,4'-bis(3-aminophenoxy)diphenylphosphonium (4,4,-bis(3-aminophenoxy)diphenylsulfone, DBSDA) and 2,2-bis[4-(4-aminophenoxy)phenyl]propane (2,2-bis[4-(4- Aminophenoxy)phenyl]propane, 6-HMDA). The polyamidamine film according to the third embodiment may have a dielectric constant of 3.0 or less at a frequency of 50 to 100 μm based on the film thickness of 50 to 100 μm. The polyamidamine film according to the third embodiment may have an average coefficient of thermal expansion (CTE) of 50 ppm or less at 50 to 200 ° C based on a film thickness of 50 to 100 μm. The polyimide film according to the third embodiment may have a modulus equal to or greater than 3.0 GPa based on a film thickness of 50 to 100 μm. The polyamidamine film according to the third embodiment may have a 50% ultraviolet cut-off wavelength of 50% or less based on the film thickness of 50 to 100 μm. The present invention can provide a polyimide resin which is colorless and transparent and has excellent properties including mechanical properties and thermal stability, and thus can be used in various fields including semiconductor insulating film, TFT_LCD insulating film, passivation film, and liquid crystal alignment layer. Optical communication materials, protective films for solar cells, and flexible display substrates. The present invention also provides a liquid crystal alignment layer and a polyimide film using the polyamidamine resin. [Simple description of the drawing] The first figure is a 15 piece of the polyimide film of Example 1 placed on a piece of paper; and the second picture is the film of the poly-branched amine of Comparative Example 1 placed on a piece of paper. photo. [Embodiment] * The present invention will be described in detail later. The polyamidamine film of the present invention is a film of a poly-anisole resin prepared from a copolymer of a diamine and a dianhydride, particularly a colorless transparent polyimide film. The polyamidamine film prepared by the invention has a film thickness of 10 1376394 of 50 to 100 μm as a reference, and the light transmittance of the external light is measured, and when it reaches nm, it has an average of 85% or more. Light transmittance, and long and ^ yellow index equal to or less than 15.

1010

此外,該聚亞酿胺膜以5〇至1〇〇 μιη的膜厚為基準, 使用紫外光分光光度計測量其透光率,於波長551至· nm時,較佳可具有等於或大於88%的平均透光率,於波長 550 nm時,較佳可具有等於或大於88%的透光率於波+ 500 nm時,較佳可具有等於或大於85%的透光率以及^ 波長420 nm時,較佳可具有等於或大於5〇%的透光率。、 符合前述透光率及黃色指數之本發明的聚亞醯胺膜, 可應用於一般習用之黃色的聚亞醯胺膜難以應用、透明度 要求高的領域’包括TFT_LCD的保護膜或是擴散板與塗 層,例如TFT-LCD的夾層(interiayer)、閘極絕緣層(〇纪6Further, the polyacrylamide film has a light transmittance measured by an ultraviolet spectrophotometer based on a film thickness of 5 Å to 1 〇〇 μηη, and preferably has a wavelength equal to or greater than 88 at a wavelength of 551 to · nm. The average light transmittance of %, when the wavelength is 550 nm, preferably has a light transmittance equal to or greater than 88% at a wavelength of +500 nm, preferably has a light transmittance equal to or greater than 85% and a wavelength 420. In the case of nm, it is preferred to have a light transmittance equal to or greater than 5%. The polyimide film of the present invention which conforms to the aforementioned light transmittance and yellow index can be applied to a conventional yellow-colored polyimide film which is difficult to apply and has high transparency requirements, including a protective film of TFT_LCD or a diffusion plate. Interlayer with a coating such as a TFT-LCD, a gate insulating layer (〇6)

Insulator)與液晶配向層。當透明的聚亞醯胺應用到液晶配 向層時,有助於增進孔隙率,因而可製造出具有高對比的 TFT-LCD,並且透明的聚亞醯胺亦可用於軟性顯示器基板 (Flexible Display Substrate)。 以50至100 μιη的膜厚為基準,本發明的聚亞醯胺膜 於波長420 nm時,可具有小於50的光學密度。符合前述 光學密度與透光率的聚亞醯胺膜,降低了用以表示穿透該 薄膜之光的散射度的折射率,是以,隨著穿透薄膜之目標 物的顏色、尺寸或位置的扭曲率降低,雙折射及延滞 (Retardation)情況亦減低。因此,本發明的聚亞醯胺膜可被 應用於要求透明度的領域中。 11 20 1376394 為達此目的,本發明所使用的芳香族二酸酐並無特別 限制,但包括一種化合物,或是二種或多種化合物的混合 物,該化合物係選自2,2_雙(3,4_二羧基苯基)六氟丙烷: 酸酐(6-FDA)、及4- (2,5-二氧四氫呋喃-3-基)4,234-5四氳化萘_1,2~·二羧酸酐(TDA)以及4,4,_ (4,4,-異丙烯基二 苯氧基)雙(鄰苯二甲酸酐)(HBDA)。 並且’本發明所使用的芳香族二胺並無特別限制,但 包括一種化合物,或是二種或多種化合物的混合物,該化 合物係選自氧化二苯胺(ODA)、1,3-雙(3-胺基苯氧基)笨 ίο (APB-133)、1,3-雙(4-胺基苯氧基)苯(APB_134)、丨,4—雙 (4-胺基苯氧基)苯(APB-144)、雙(3-胺基苯基)^ (3-DDS)、雙(4-胺基笨氧基)砜(4-DDS)、2,2’_雙(三氟 曱基)-4,4’-二胺基聯苯(2,2’-丁卩03)、3,3,-雙(三氟曱基) -4,4’_二胺基聯苯(3,3’-TFDB)、2,2’-雙[4 (4-胺基苯氧基) 15苯基]六氟丙烷(4-BDAF)、2,2’-雙[3 ( 3-胺基苯氧基)苯基] 六氟丙烷(3-BDAF)、4,4’-雙(3-胺基苯氧基)二苯基颯 (DBSDA)以及2,2-雙[4- (4-胺基苯氧基)苯基]丙烷 (6-HMDA)。 二酸針及二胺係以等莫耳量溶解於有機溶劑中,之後 20進行反應,以製備聚酿胺酸溶液。 反應條件並無特別限制’但包括負20至80°C的反應 溫度,以及2至48小時的反應時間◊此外,反應宜在氬氣 或氮氣的惰性氣體環境中進行。 用於單體之溶液聚合反應的有機溶劑,並無特別限 12 1376394 制’只要聚醯胺酸能夠溶解於其内即可。一般已知的反應 溶劑中’係使用一種或多種選自下列的極性溶劑:間—甲 酚、Ν-甲基-2_π比咯烧酮(ΝΜΡ)、二曱基曱酿胺(DMF)、二 甲基乙醯胺(DMAc)、二甲基亞砜(DMSO)、丙酮以及二乙 5基醋酸鹽。此外,亦可使用低沸點溶劑,諸如四氫呋喃(THF) 或氯仿,或是低吸收性溶劑,諸如γ-丁内酯。Insulator) and liquid crystal alignment layer. When transparent polyimide is applied to the liquid crystal alignment layer, it contributes to the improvement of porosity, so that a TFT-LCD with high contrast can be manufactured, and transparent polyimide can also be used for a flexible display substrate (Flexible Display Substrate) ). The polyiminium film of the present invention may have an optical density of less than 50 at a wavelength of 420 nm based on a film thickness of 50 to 100 μm. A polyimide film conforming to the aforementioned optical density and light transmittance lowers the refractive index used to indicate the degree of scattering of light penetrating the film, so that the color, size or position of the target that penetrates the film The distortion rate is reduced, and the birefringence and retardation are also reduced. Therefore, the polyamidamine film of the present invention can be applied to a field requiring transparency. 11 20 1376394 For the purpose of this invention, the aromatic dianhydride used in the present invention is not particularly limited, but includes a compound or a mixture of two or more compounds selected from 2,2_bis (3, 4-dicarboxyphenyl)hexafluoropropane: anhydride (6-FDA), and 4-(2,5-dioxotetrahydrofuran-3-yl)4,234-5 tetradecylnaphthalene_1,2~·dicarboxylic anhydride (TDA) and 4,4,_(4,4,-isopropenyldiphenoxy)bis(phthalic anhydride) (HBDA). And the aromatic diamine used in the present invention is not particularly limited, but includes a compound or a mixture of two or more compounds selected from the group consisting of oxidized diphenylamine (ODA) and 1,3-double (3). -aminophenoxy) stupid (APB-133), 1,3-bis(4-aminophenoxy)benzene (APB_134), anthracene, 4-bis(4-aminophenoxy)benzene ( APB-144), bis(3-aminophenyl)^(3-DDS), bis(4-aminophenyloxy)sulfone (4-DDS), 2,2'-bis(trifluoromethyl) -4,4'-diaminobiphenyl (2,2'-butane 03), 3,3,-bis(trifluoromethyl)-4,4'-diaminobiphenyl (3,3' -TFDB), 2,2'-bis[4 (4-aminophenoxy) 15 phenyl]hexafluoropropane (4-BDAF), 2,2'-bis[3 (3-aminophenoxy) Phenyl]hexafluoropropane (3-BDAF), 4,4'-bis(3-aminophenoxy)diphenylphosphonium (DBSDA) and 2,2-bis[4-(4-aminobenzene) Oxy)phenyl]propane (6-HMDA). The diacid needle and the diamine are dissolved in an organic solvent in an equivalent molar amount, and then reacted 20 to prepare a poly-branched acid solution. The reaction conditions are not particularly limited, but include a reaction temperature of minus 20 to 80 ° C and a reaction time of 2 to 48 hours. Further, the reaction is preferably carried out under an inert gas atmosphere of argon or nitrogen. The organic solvent used for the solution polymerization of the monomer is not particularly limited as long as the polylysine can be dissolved therein. In the generally known reaction solvent, one or more polar solvents selected from the group consisting of m-cresol, hydrazine-methyl-2_πpyrrolidone (oxime), dimercaptomannamine (DMF), and two are used. Methylacetamide (DMAc), dimethyl sulfoxide (DMSO), acetone, and diethyl 5-acetate. Further, a low boiling point solvent such as tetrahydrofuran (THF) or chloroform or a low absorption solvent such as γ-butyrolactone may also be used.

有機溶劑的用量並無特別限制,而為了得到具有適當 分子量與黏度的聚醯胺酸溶液,以聚醯胺酸溶液的總量為 基準,有機溶劑的使用量較佳為至95重量百分比 ίο (wt%)’且更佳為70至90重量百分比。 15 20 鈣、磷酸鈣及雲母 此外,當聚亞醯胺膜係使用聚醯胺酸溶液來製造時, &lt;添加填骸《胺,以增輯麵贿的種種 性質,包㈣動性、導熱性、導電性及耐電暈性。填料並 無特別限制,但其具體範例包括二氧切、氧化鈦 '層狀 二氧化梦、奈米碳管、氧化紹、氮化梦、氮化哪、鱗酸氮 填料的粒徑可視欲修飾之薄膜的性質及添加之填料的 類型而異’並無㈣㈣。填料的平均粒 至5〇叫的範圍内,更佳在嶋至25卿的範圍内二 佳在0.01至10 μηι的範圍内。於此愔 輕易:有效地被修飾,且亦可展現出良好的表面=膜; 電性與機械性質- 導 填料的用量可視欲修飾之薄膜的性質 異,但無特別限制^以!〇〇番曰、科的粒仨而 重S:伤的t酿胺酸溶液為基準, 13 至20重量份,較佳為0.01至10重 填料的添加量為0.001 量份。 取人;5 t的Ϊ加方法並無制限制,但舉例來說,包括於 :缺或之後將填料添加到雜胺酸溶液、完成聚 =溶液的聚合反應後,使用三_磨機揉混填料成: 疋s有填料的分散溶液與聚酿胺暖溶液混合。 使用以此方式所獲得之聚醢胺酸溶液,來製造聚亞酿 胺膜的方法並無特別限制,任何f用的已知方法均可採 用。聚醒麟缝的魏胺化包括,例如熱亞醯胺化及化 學f酿胺化,其中以化學亞醯胺化特別有效。化學亞酿胺 化疋藉由將脫水劑,包括酸野,例如醋酸針,以及亞酿胺 化催化劑’包括三級胺,例如異啥淋、P_甲基π比咬、或吨 啶,添加到聚醯胺酸溶液中來進行。化學亞醯胺化可伴隨 熱亞醯胺化一起進行,且加熱條件可視聚醯胺酸溶液的 型及薄膜的厚度而異。 藉由在80至200〇c下,較佳為在1〇〇至18〇〇C下,加 熱基板上的聚醯胺酸溶液,以活化脫水劑與亞醯胺化催化 劑元成部分硬化與乾無以得到凝膠態的聚酿胺酸膜、將 聚醯胺酸膜與基板分離、以及於200至400。〇下加熱凝膠 態的薄膜5至400秒等步驟,以獲得聚亞醯胺膜。 ^ 以此所獲得之聚亞醯胺膜的厚度並無特別限制,但考 慮到其應用領域’則膜厚較佳為在10至250 μηι的範圍内, 更佳為在25至150 μπι的範圍内。 本發明的聚亞醯胺膜於1 GHz時,具有等於或小於3 1376394 的介電常數’因而可用來作為半導體鈍化(passivati〇n)膜。 本發明的聚亞醯胺膜於.50至2〇〇。(:時,具有等於或小 於50 ppm的平均熱膨脹係數。若平均熱膨脹係數超過5〇 ppm時,當聚亞醯胺膜應用於將薄獏電晶體(TFT)置放到薄 5膜上的薄膜電晶體陣列(TFT ARRAY)製程時,聚亞醯胺膜 可能會隨者不同的製程溫度而收縮或膨脹,導致在電極換 雜製程中無法達成配向。此外,薄膜亦無法保持平整,因 而可能捲繞。所以’當熱膨服係數減低時,TFT製程才可 能更準確地進行。 10 本發明的聚亞酿胺膜具有等於或大於3.0 GPa的模 數。在此範例中,聚亞醯胺膜可更輕易地被應用於軟性顯 示器基板的捲壓(Roll to Roll)製程。當聚亞醯胺膜被用來作 為軟性顯示器(Flexible Display)與軟性銅箔基板(FCCL)的 基膜時,係進行捲壓製程。此時,因為薄膜被滾筒捲繞以 is及自滾筒釋放時,薄膜會受到拉力,所以模數低於3 〇Gpa 的薄膜可能會斷裂。 依據使用紫外光分光光度計的透光率測量,本發明之 聚亞醯胺膜具有等於或小於400 nm之50%截止波長。因 此本發明的聚亞醯胺膜可用來作為太陽能電池用的 • 20 保護骐。 • 絲舉下列各範例以更加瞭解本發明,但所舉各範例不 得解釋為限制本發明。 &lt;範例1&gt; 當氮氣通過配備有攪拌器、氮氣入口、滴液漏斗、控 15 1376394 溫器以及冷凝器之100 mL的三頸(3-Neck)圓底燒瓶反應裝 置時’將32.4623克的N,N-二甲基乙醯胺(DMAc)加入該圓 底燒瓶内,並將反應裝置的溫度降低到〇。〇,再將4.1051 克(0.01莫耳)的6-HMDA溶解於其内。將此溶液保持在 5 〇°C 的溫度。將 3.1097 克(0.007 莫耳)的 6-FDA 和 0.90078 克(0.003莫耳)的TDA加入溶液中,並攪拌此混合物j 小時’直到6-FDA與TDA完全溶解。此溶液的固體含量為 2〇重量百分比(wt%)。在室溫條件下將獲得的溶液攪拌8 小時’以產生於23°C時,黏度為2200 cps的聚酿胺酸溶液。 10 其後,使用刮刀(Doct〇r Blade)在玻璃基板上塗敷厚度 500至1〇〇〇 μιη的聚酿胺酸溶液,再於真空烘箱中以4〇〇c 的溫度乾燥1小時,和以60。(:的溫度乾燥2小時,以產生 一種自立薄膜(Self Standing Film)。接著,讓此薄膜在高溫 烘箱中以每分鐘5°C的加熱速率,分別在8〇°c下硬化3小 15時、下硬化1小時、200Χ下硬化1小時以及3〇〇〇C 下硬化30分鐘,以產生厚度為5〇 μιη和loo 的聚亞酿 胺膜。 &lt;範例2&gt; 如同範例1,4.1051克(〇.〇1莫耳)的6_HMDA係溶 2〇解於31.3106克的DMAc中,並將此溶液保持在〇〇c的溫 度。將 2.2215 克(0.005 莫耳)的 6-FDA 和 1.5013 克(0.005 莫耳)的TDA依序加入溶液中,並攪拌此溶液1小時,直 到6-FDA與TDA完全溶解。溶液的固體含量為2〇重量百 分比(wt%)。然後,在室溫條件下將獲得的溶液攪拌8小時, 16 1376394 以產生於23°C時’黏度為2000 cps的聚酿胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例3&gt; 如同範例1 ’ 4·1051克(〇·〇1莫耳)的6-HMDA係溶 5解於30.15868克的DMAc中,並將此溶液保持在〇〇c的溫 度。將 1.11275 克(0.003 莫耳)的 6-FDA 和 2.10182 克(0.007 莫耳)的TDA依序加入溶液中,並將溶液攪拌1小時,直 到6-FDA與TDA完全溶解》溶液的固體含量為2〇重量百 分比(wt%)。然後,在室溫條件下將溶液攪拌8小時,以產 生於23°C時,黏度為1800 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例4&gt; 如同範例1 ’ 2.87357克(0.007莫耳)的6-HMDA係 溶解於30.5丨58克的DMAc中,再將〇.7449克(0.003莫耳) 15的3_DDS加入’並使其完全溶解。將3.1097克(0.007莫 耳)的6-FDA和0.90078克(0.003莫耳)的TDA依序加 入溶液中,將溶液攪拌1小時,直到6-FDA與TDA完全溶 解°溶液的固體含量為20重量百分比(wt%)。然後,在室 溫條件下將獲得的溶液攪拌8小時,以產生一種於230C 20時,黏度為2000 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例5&gt; 如同範例1 ’ 2.87357克(0.007莫耳)的6-HMDA係 溶解於30.5158克的DMAc中,再將0.7449克(0.003莫耳) 17 的4_DDS加入溶液中,並使其完全溶解。將3.順克(0.007 莫耳)的6-FDA和0.9_克(_莫耳)的皿依序 加入溶液中,並將溶_拌i小時,直到6 FDA與皿 元全溶解。溶液的固體含量為2 〇重量百分比(wt %)。然後, 5在室溫條件下賴得的溶_拌8㈣,以產生於抓 時,黏度為2000 cps的聚醯胺酸溶液。 其後’採用如同範例i的方式製造聚亞酿胺膜。 &lt;範例6&gt; 如同範例1 ’ 2.24161克(〇.007莫耳)的2,2,_TFDB和 1〇 0.7449克(0.003莫耳)的3_DDS係溶解於98796克的 DMAc 中。將 3 1〇97 克(〇 〇〇7 莫耳)的 6 FDA 和 〇 9〇〇78 克^0‘003莫耳)的TDA依序加入溶液中,並將溶液授拌1 J犄胃直到6-FDA與TDA完全溶解。溶液的固體含量為 2〇重®百分比(wt%卜然後,在室溫條件下將溶液授摔8 J時以產生於23T時’黏度為2000 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例7&gt; 如同範例卜2.24161克(0.007莫耳)的2,2,-TFDB和 〇’7449克(0.003莫耳)的4-DDS,係溶解於27.98790克 2〇 的 DMAC 中。將 3.1097 克(0.007 莫耳)的 6-FDA 和 0.90078 克(0.003莫耳)的tda依序加入溶液中,並將溶液授拌1 小時,直到6-FDA與TDA完全溶解。溶液的固體含量為 20重置百分比(wt%)。然後,在室溫條件下將溶液攪拌8 】寺以產生於23°C時,黏度為2000 cps的聚酿胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜, &lt;範例8&gt; 如同範例1,3.62922克(〇·007莫耳)的4_BDAF係溶 解於33.5386克的DMAc中,再將〇 7449克(〇 〇〇3莫耳) 5的3_DDSM入溶液中’並使其完全溶解。將3.1097克(0.007 莫耳)的6-FDA和0.90078克(0.003莫耳)的TDA依序 加入;谷液中,並將溶液攪拌1小時,直到6_fda與TDA 完全溶解。溶液的固體含量為20重量百分比(wt%)。然後, 在室溫條件下將溶液攪拌8小時,以產生於23〇c時,黏度 ⑴為2200 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例9&gt; 如同範例1 ’ 3.62922克(0.007莫耳)的4-BDAF係溶 解於33.5386克的DMAc中,再將0 7449克(〇.〇〇3莫耳) 的4-DDS加入溶液中,並使其完全溶解。將3 1〇97克(〇 〇〇7 莫耳)的6-FDA和0.90078克(ο·莫耳)的TDA依序 加入溶液中,並將溶液攪拌丨小時,直到6_FDA與tda 完全溶解。溶液的固體含量為2Q重量百分比(wt%)。然後, 在室溫條件下將溶液游8小時,以產生於23T時,黏度 2〇為2100 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例1〇&gt; 如同範例1,2.04631克(0.007莫耳)的ΑΡΒ·133和 0.7449克(0.003莫耳)的3_DDS,係完全溶解於27.20696 1376394 克的DMAc中。將3.10975克(0.007莫耳)的6-FDA和 0.90078克(0.003莫耳)的TDA依序加入溶液中,並將獲 得的溶液攪拌1小時,直到6-FDA與TDA完全溶解。溶液 的固體含里為20重量百分比(wfo/o)。然後,在室溫條件下 5將溶液攪拌8小時,以產生於23。€時,黏度為19〇〇卬3的 .聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例11&gt; 如同範例1,2.04631克(0.007莫耳)的APB-133和 1〇 0.7449克(0.003莫耳)的4_DDS,係完全溶解於27 2〇696 克的DMAC中。將3.10975克(0.007莫耳)的6_FDA和 0.90078克(0.003莫耳)的TDA依序加入溶液中並將混 合物攪拌1小時,直到6_FDA與TDA完全溶解。所獲得之 溶液的固體含量為20重量百分比(wt%)。然後,在室溫條 I5件下將溶液攪拌8小時,以產生於23。&lt;:時,黏度為i95〇cps 的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例12&gt; 如同範例1,3.2023克(0.01莫耳)的2,2,_TFDB係完 全溶解於30,986克的DMAc中。將此溶液保持在〇τ的溫 度。將 3.64355 克(0.007 莫耳)的 6-HBDA 和 0.90078 克 (0.003莫耳)的TDA依序加入溶液中,並將混合物攪拌工 小時二直到6-HBDA與TDA完全溶解。所獲得之溶液的固 體含量為20重量百分比(wt%) 然後,在室溫條件下將溶 20 1376394 液攪拌8小時,以產生於23Τ時,黏度為2〇〇〇 cps的聚醯 胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例13&gt; 5 如同範例1,2.483克(0.01莫耳)的4-DDS係溶解於 28.1093克的DMAc中,將溶液保持在〇〇c的溫度。將 3.64355 克(0.007 莫耳)的 6-HBDA 和 0.90078 克(0.003 莫耳)的TDA依序加入溶液中,並將溶液攪拌丨小時,直 到6-HBDA與TDA完全溶解。溶液的固體含量為2〇重量 1〇百分比(wt%)。然後,在室溫條件下將溶液攪拌8小時,以 產生於23°C時,黏度為1800 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例14&gt; 如同範例卜5.1846克(〇.〇1莫耳)的4-BDAF係溶解 於38.9157克的DMAc中,並將溶液保持在的溫度。 將 3.64355 克(0.007 莫耳)的 6-HBDA 和 0.90078 克(0.003 莫耳)的TDA依序加入溶液中,並將溶液攪拌丨小時,直 到6-HBDA與TDA完全溶解。溶液的固體含量為2〇重量 百分比(wt°/〇)。然後’在室溫條件下將溶液攪拌8小時,以 .2〇產生於23°C時,黏度為2〇〇〇CpS的聚酿胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例15&gt; 如同範例1,2.24161克(0·007莫耳)的2,2,-TFDB和 0.7449克(0.003莫耳)的4-DDS,係完全溶解於30 3628 21 1376394 克的DMAc中❶將溶液保持在的溫度。將3 6435克 (0.007莫耳)的6_HBDA和〇.96〇69克⑽〇3莫耳)的 TDA依序加入溶液中,並攪拌1小時,直到6_ηβ〇α與 完全溶解。溶液的固體含量為20重量百分比(wt%)/然後, 5在至溫條件下將溶液搜拌8小時,以產生於23〇c時,黏度 為1700 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例16&gt; 如同範例1,3.62922克(0.007莫耳)的3-BDAF和 10 0.7449克(0.003莫耳)的4-DDS,係完全溶解於35.91324 克的DMAc中。將溶液保持在〇〇c的溫度。將3 6435克 (0.007 莫耳)的 6-HBDA 和 0.96069 克(0.003 莫耳)的 TDA依序加入溶液中,並攪拌1小時,直到6_HBDA與TDA 完全溶解。溶液的固體含量為20重量百分比(wt%)。然後, I5在室溫條件下將溶液搜拌8小時,以產生於23。(:時,黏度 為1700 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例17&gt; 如同範例1 ’ 2.24161克(0.007莫耳)的2,2,-TFDB和 20 1.5 5 5 3 8克(0.003莫耳)的3-BDAF,係加入並完全溶解於 33.60472克的DMAc中。將溶液保持在〇。(:的溫度。將 3.6435 克(0.007 莫耳)的 6-HBDA 和 0.96069 克(0.003 莫耳)的TDA依序加入溶液中’並授拌1小時,直到6_hbda 與TDA完全溶解❶溶液的固體含量為2〇重量百分比 22 (Wt%)。然後’在室溫條件下將溶液攪拌8小時,以產生於 23 C時’點度為18〇〇 CpS的聚酿胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;比較範例1&gt; 5 如同範例1,5.1846克(0.01莫耳)的4-BDAF係溶解 於38.5084克的DMAc中,接著將4.4425克(0.01莫耳) 的6-FDA加入。將溶液攪拌1小時,直到6_FDA完全溶解。 溶液的固體含量為20重量百分比(wt%)。然後,在室溫條 件下將溶液攪拌8小時,以產生於23。(:時,黏度為1300 cps 10的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜,而所 得之膜厚分别為 25 μιη,50 μιη 及 1〇〇 。 &lt;比較範例2&gt; 如同範例1 ’ 2.9233克(0.01莫耳)的ΑΡΒ-133係溶 15解於29.4632克的DMAc中,接著將4.4425克(0.01莫耳) 的6-FDA加入。將溶液攪拌1小時’直到6_FDA完全溶解。 溶液的固體含量為20重量百分比(wt%)。然後,在室溫條 件下將溶液攪拌8小時’以產生於23°C時,黏度為1200 cps 的聚醯胺酸溶液。 20 其後’採用如同比較範例1的方式製造聚亞醯胺膜。 &lt;比較範例3&gt; 如同範例1 ’ 2.4830克(0.01莫耳)的3_DDS係溶解 於27.702克的DMAc中,接著將4.4425克(〇 莫耳)的 6-FDA加入。將溶液攪拌1小時,直到6_FDA完全溶解。 23 1376394 溶液的固體含量為2〇重蕃τ、 件下將溶_拌8小時,^ ^比(Wt%)、#:後’在室溫條 的聚酿胺酸溶液。 於23 C時’黏度為1300 cps 1的方·造聚亞酿胺膜。 如同範例卜2.4830克rnm垃 於27.7〇2克的DMAct技(,莫耳〕的4_DDS係溶解 ίο 6遍加入。將溶液_ f:T5克(〇.〇if:)的 溶液的固體含量為2G重量百,、到6_FDA&quot;°全'谷解。 件下將溶賴掉8小時,。纽’在室溫條 的聚酿胺酸溶液。產生於23 C時,黏度為啊 其後,採用如同比較範例1的方式製造聚亞醯胺膜。 &lt;比較範例5&gt; 如同範例卜2.0024克(〇.〇1莫耳)的3,3,-〇da係溶 鲁15解於25.7796克的DMAc中,接著將4 4425克(〇〇1莫耳) 的6-FDA加入,並將獲得的溶液攪拌i小時,直到6_fda ; 完全溶解。溶液的固體含量為20重量百分比(wt%)。然後, 在室溫條件下將溶液擾拌8小時,以產生於23°C時,黏度 • 為1600 cps的聚酿胺酸溶液。 20 其後,採用如同比較範例1的方式製造聚亞醯胺膜。 ’ &lt;比較範例6&gt;The amount of the organic solvent to be used is not particularly limited, and in order to obtain a polyamic acid solution having an appropriate molecular weight and viscosity, the organic solvent is preferably used in an amount of up to 95% by weight based on the total amount of the polyamic acid solution. It is preferably from 70 to 90% by weight. 15 20 Calcium, Calcium Phosphate and Mica In addition, when the polyamidomethine membrane is made of polylysine solution, &lt;addition of the amine to increase the nature of the bribe, package (four) dynamic, thermal conductivity Sex, conductivity and corona resistance. The filler is not particularly limited, but specific examples thereof include dioxy-cut, titanium oxide 'layered dioxide dioxide dream, nano carbon tube, oxidized sulphur, nitriding dream, nitriding, sulphate nitrogen filler particle size can be modified The nature of the film and the type of filler added vary from 'four' (iv). The average particle size of the filler is in the range of 5 Torr, more preferably in the range of 至 to 25 qing in the range of 0.01 to 10 μη. Here 轻易 Easily: effectively modified, and can also exhibit a good surface = film; electrical and mechanical properties - the amount of filler can be used depending on the nature of the film to be modified, but no special restrictions ^! The granules of the 〇〇 曰 曰 科 科 科 科 科 : : : : : : : 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿 酿There is no restriction on the addition method of 5 t, but for example, it is included in: after adding or adding the filler to the heteroamine solution, after completing the polymerization of the poly-solution, using the tri-mill to mix the filler Form: 疋s The dispersed solution with filler is mixed with the warm solution of polyamine. The method for producing the polyaramine film by using the polyamic acid solution obtained in this manner is not particularly limited, and any known method for use can be employed. The amination of the polyunion includes, for example, thermal amidation and chemical amination, wherein chemical amidation is particularly effective. Chemically brewed amidoxime is added by adding a dehydrating agent, including acid fields, such as acetic acid needles, and a chitinizing catalyst, including tertiary amines, such as isoindole, P-methyl pi-bite, or tonidine. It is carried out in a polyamic acid solution. The chemical imidization can be carried out together with the thermal amidation, and the heating conditions may vary depending on the type of the polyamic acid solution and the thickness of the film. The poly-proline solution on the substrate is heated at 80 to 200 ° C, preferably at 1 to 18 ° C, to partially harden and dry the activated dehydrating agent and the amidoxime catalyst. It is not possible to obtain a gelatinized polyacrylic acid film, to separate the polyamic acid film from the substrate, and to be in the range of 200 to 400. The film in the gel state is heated under the arm for 5 to 400 seconds to obtain a polyimide film. The thickness of the polyimide film obtained by the film is not particularly limited, but the film thickness is preferably in the range of 10 to 250 μm, more preferably in the range of 25 to 150 μm, in view of the field of application. Inside. The polyamidamine film of the present invention has a dielectric constant at or below 3 1376394 at 1 GHz and thus can be used as a semiconductor passivation film. The polyamidamine film of the present invention is at -50 to 2 Torr. (: when having an average coefficient of thermal expansion equal to or less than 50 ppm. If the average coefficient of thermal expansion exceeds 5 〇 ppm, when a polyimide film is applied to a film on which a thin tantalum transistor (TFT) is placed on a thin film 5 In the TFT ARRAY process, the polyimide film may shrink or swell with different process temperatures, resulting in failure to achieve alignment in the electrode replacement process. In addition, the film cannot be kept flat, and thus may be rolled. Therefore, the TFT process may be performed more accurately when the coefficient of thermal expansion is reduced. 10 The polyacrylamide film of the present invention has a modulus equal to or greater than 3.0 GPa. In this example, a polyimide film It can be more easily applied to the Roll to Roll process of flexible display substrates. When polyimide film is used as the base film of flexible display and soft copper foil substrate (FCCL), The roll pressing process is carried out. At this time, since the film is subjected to tension when it is wound by the drum and released from the drum, the film having a modulus of less than 3 〇Gpa may be broken. According to the use of the ultraviolet spectrophotometer. For the light rate measurement, the polyamidamine film of the present invention has a cutoff wavelength of 50% or less of 400 nm. Therefore, the polyimide film of the present invention can be used as a 20 骐 for solar cells. The examples are intended to further understand the present invention, but the examples are not to be construed as limiting the invention. <Example 1> When nitrogen is passed through a 100 mL equipped with a stirrer, a nitrogen inlet, a dropping funnel, a 15 1376394 temperature regulator, and a condenser In a three-neck (3-Neck) round bottom flask reaction apparatus, 32.4623 g of N,N-dimethylacetamide (DMAc) was added to the round bottom flask, and the temperature of the reaction apparatus was lowered to 〇. Then, dissolve 4.1051 g (0.01 mol) of 6-HMDA. Keep this solution at 5 ° C. 3.097 g (0.007 mol) of 6-FDA and 0.90078 g (0.003 mol) TDA was added to the solution and the mixture was stirred for 1 hour until the 6-FDA and TDA were completely dissolved. The solid content of this solution was 2% by weight (wt%). The obtained solution was stirred for 8 hours at room temperature. 'With a viscosity of 2200 cps at 23 ° C A solution of the amino acid. 10 Thereafter, a poly(lanine) solution having a thickness of 500 to 1 μm was applied to the glass substrate using a doctor blade (Doct〇r Blade), and dried at a temperature of 4 〇〇c in a vacuum oven. After 1 hour, and dried at a temperature of 60 ° (:: 2 hours) to produce a Self Standing Film. Then, the film was allowed to heat at a temperature of 5 ° C per minute in a high temperature oven at 8 ° C. C was hardened at 3 hours and 15 hours, hardened for 1 hour, hardened at 200 1 for 1 hour, and hardened at 3 〇〇〇C for 30 minutes to produce a poly-aniline film having a thickness of 5 μm and loo. &lt;Example 2&gt; As in Example 1, 4.1051 g (〇.〇1 mol) of 6_HMDA was dissolved in 31.3106 g of DMAc, and this solution was maintained at a temperature of 〇〇c. 2.2215 g (0.005 mol) of 6-FDA and 1.5013 g (0.005 mol) of TDA were added to the solution sequentially, and the solution was stirred for 1 hour until the 6-FDA and TDA were completely dissolved. The solid content of the solution was 2% by weight (wt%). Then, the obtained solution was stirred at room temperature for 8 hours, 16 1376394 to give a poly-branched acid solution having a viscosity of 2000 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 3&gt; As in Example 1 '4·1051 g (〇·〇1 mol), 6-HMDA was dissolved in 30.15868 g of DMAc, and this solution was maintained at a temperature of 〇〇c. Add 1.11275 grams (0.003 moles) of 6-FDA and 2.10182 grams (0.007 moles) of TDA to the solution and stir the solution for 1 hour until the 6-FDA and TDA are completely dissolved. The solids content of the solution is 2. 〇 Weight percent (wt%). Then, the solution was stirred at room temperature for 8 hours to give a polyamic acid solution having a viscosity of 1800 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 4&gt; As in Example 1 ' 2.87357 g (0.007 mol) of 6-HMDA was dissolved in 30.5 丨 58 g of DMAc, and then 449. 7449 g (0.003 mol) 15 of 3_DDS was added to 'and completely dissolved. 3.1097 g (0.007 mol) of 6-FDA and 0.90078 g (0.003 mol) of TDA were sequentially added to the solution, and the solution was stirred for 1 hour until the 6-FDA and TDA were completely dissolved. The solid content of the solution was 20 weight. Percentage (wt%). Then, the obtained solution was stirred at room temperature for 8 hours to produce a polylysine solution having a viscosity of 2000 cps at 230 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 5&gt; As in Example 1 ' 2.87357 g (0.007 mol) of 6-HMDA was dissolved in 30.5158 g of DMAc, and 0.7449 g (0.003 mol) of 17_DDS was added to the solution and completely dissolved. . 3. Shunke (0.007 mol) of 6-FDA and 0.9 g (_mole) dishes were sequentially added to the solution, and the solution was mixed for 1 hour until the 6 FDA and the dish were completely dissolved. The solids content of the solution was 2% by weight (wt%). Then, 5 at room temperature, the solution was mixed with 8 (four) to produce a polylysine solution having a viscosity of 2000 cps at the time of scratching. Thereafter, a poly-aniline film was produced in the same manner as in Example i. &lt;Example 6&gt; A 3D system of 2,2,_TFDB and 1〇0.7449 g (0.003 mol) as in Example 1' 2.24161 g (〇.007 mol) was dissolved in 98796 g of DMAc. Add 3 1〇97 g (〇〇〇7 摩尔) of 6 FDA and 〇9〇〇78 g^0'003 mol of TDA to the solution in sequence, and mix the solution with 1 J 犄 stomach until 6 - FDA and TDA are completely dissolved. The solid content of the solution is 2% by weight of the percentage (wt%, then, at room temperature, the solution is dropped to 8 J to produce a polylysine solution having a viscosity of 2000 cps at 23 T. Thereafter, The polyimide film was produced in the manner of Example 1. &lt;Example 7&gt; As in the example, 2.24161 g (0.007 mol) of 2,2,-TFDB and 〇'7449 g (0.003 mol) of 4-DDS were dissolved. In 27.98790 g of 2 〇 DMAC, 3.1097 g (0.007 mol) of 6-FDA and 0.90078 g (0.003 mol) of tda were sequentially added to the solution, and the solution was mixed for 1 hour until 6-FDA and The TDA was completely dissolved. The solids content of the solution was 20% by weight (wt%). Then, the solution was stirred at room temperature to give a solution of urethane at a viscosity of 2000 cps at 23 °C. Thereafter, a polyamidamine film was produced in the same manner as in Example 1, &lt;Example 8&gt; As in Example 1, 3.62292 g (〇·007 Moel) of 4_BDAF was dissolved in 33.5386 g of DMAc, and then 〇7449 g (〇〇〇3mol) 5 of 3_DDSM into solution' and make it completely dissolved. Will be 3.1097 g (0.007 mol) 6-FDA and 0.90078 g (0.003 mol) of TDA were added sequentially; in the solution, the solution was stirred for 1 hour until 6-fda was completely dissolved with TDA. The solids content of the solution was 20 weight percent (wt%). Then, the solution was stirred at room temperature for 8 hours to give a polyamine solvent solution having a viscosity (1) of 2200 cps at 23 ° C. Thereafter, a polyimide film was produced in the same manner as in Example 1. Example 9&gt; As in Example 1 ' 3.62922 g (0.007 mol) of 4-BDAF was dissolved in 33.5386 g of DMAc, and then 0 7449 g (〇.〇〇3 mol) of 4-DDS was added to the solution. And completely dissolve it. Add 3 1 〇 97 g (〇〇〇 7 摩尔) of 6-FDA and 0.90078 g (ο·mol) of TDA to the solution, and stir the solution for 丨 hours until 6 _FDA Completely dissolved with tda. The solid content of the solution was 2Q weight percent (wt%). Then, the solution was allowed to swim for 8 hours at room temperature to produce a polyaminic acid solution having a viscosity of 2100 cps at 23T. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 1〇&gt; As Example 1, 2.04 631 g (0.007 mol) of ΑΡΒ·133 and 0.7449 g (0.003 mol) of 3_DDS were completely dissolved in DMAc of 27.20696 1376394 g. 3.10975 grams (0.007 moles) of 6-FDA and 0.90078 grams (0.003 moles) of TDA were sequentially added to the solution, and the obtained solution was stirred for 1 hour until the 6-FDA and TDA were completely dissolved. The solids of the solution contained 20% by weight (wfo/o). Then, the solution was stirred at room temperature for 5 hours to give 23. At a time, the viscosity is 19〇〇卬3. Poly-proline solution. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 11&gt; As in Example 1, 2.04631 g (0.007 mol) of APB-133 and 1 〇 0.7449 g (0.003 mol) of 4_DDS were completely dissolved in 27 2 696 g of DMAC. 3.10975 grams (0.007 moles) of 6_FDA and 0.90078 grams (0.003 moles) of TDA were added sequentially to the solution and the mixture was stirred for 1 hour until 6_FDA and TDA were completely dissolved. The solid content of the obtained solution was 20% by weight (wt%). Then, the solution was stirred for 8 hours under room temperature I5 to give 23. &lt;:, a polyaminic acid solution having a viscosity of i95 〇 cps. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 12&gt; As in Example 1, 3.2023 g (0.01 mol) of 2,2,_TFDB was completely dissolved in 30,986 g of DMAc. This solution was maintained at a temperature of 〇τ. 3.64355 g (0.007 mol) of 6-HBDA and 0.90078 g (0.003 mol) of TDA were sequentially added to the solution, and the mixture was stirred for two hours until 6-HBDA and TDA were completely dissolved. The solid content of the obtained solution was 20% by weight (wt%). Then, the solution of 20 1376394 was stirred at room temperature for 8 hours to produce a polyaminic acid solution having a viscosity of 2 〇〇〇 cps at 23 Torr. . Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 13&gt; 5 As in Example 1, 2.48 g (0.01 mol) of 4-DDS was dissolved in 28.1093 g of DMAc, and the solution was maintained at the temperature of 〇〇c. 3.64355 g (0.007 mol) of 6-HBDA and 0.90078 g (0.003 mol) of TDA were added to the solution sequentially, and the solution was stirred for a few hours until 6-HBDA and TDA were completely dissolved. The solids content of the solution was 2% by weight and 1% by weight (wt%). Then, the solution was stirred at room temperature for 8 hours to give a polyamic acid solution having a viscosity of 1800 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 14&gt; As in the example, 5.1846 g (〇.1 mol) of 4-BDAF was dissolved in 38.9157 g of DMAc, and the solution was maintained at the temperature. 3.64355 g (0.007 mol) of 6-HBDA and 0.90078 g (0.003 mol) of TDA were added to the solution sequentially, and the solution was stirred for a few hours until 6-HBDA and TDA were completely dissolved. The solids content of the solution was 2% by weight (wt ° / 〇). Then, the solution was stirred at room temperature for 8 hours to give a polyacrylic acid solution having a viscosity of 2 〇〇〇 CpS at 23 ° C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 15&gt; As in Example 1, 2.22161 g (0·007 mol) of 2,2,-TFDB and 0.7449 g (0.003 mol) of 4-DDS were completely dissolved in DMAc of 30 3628 21 1376394 g ❶ Keep the solution at the same temperature. 3 6435 g (0.007 mol) of 6_HBDA and 〇.96 〇 69 g (10) 〇 3 mol of TDA were sequentially added to the solution and stirred for 1 hour until 6 ηβ〇α was completely dissolved. The solid content of the solution was 20 weight percent (wt%) / then, 5, the solution was mixed for 8 hours under temperature conditions to give a polyamine solution having a viscosity of 1700 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 16&gt; As in Example 1, 3.62922 g (0.007 mol) of 3-BDAF and 10 0.7449 g (0.003 mol) of 4-DDS were completely dissolved in 35.91324 g of DMAc. The solution is maintained at the temperature of 〇〇c. 3 6435 g (0.007 mol) of 6-HBDA and 0.96069 g (0.003 mol) of TDA were sequentially added to the solution and stirred for 1 hour until 6_HBDA and TDA were completely dissolved. The solid content of the solution was 20 weight percent (wt%). Then, I5 was mixed for 8 hours at room temperature to give at 23. (:, a polyamic acid solution having a viscosity of 1700 cps. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 17&gt; As in Example 1 ' 2.24161 g (0.007 m) 2, 2,-TFDB and 20 1.5 5 5 3 8 g (0.003 mol) of 3-BDAF were added and completely dissolved in 33.60472 g of DMAc. The solution was kept at 〇. (: temperature. 3.6435 g (0.007 6-HBDA of Mohr and 0.96069 g (0.003 mol) of TDA were added to the solution sequentially and allowed to mix for 1 hour until the solid content of 6_hbda and TDA was completely dissolved. The solid content of the solution was 2% by weight 22 (Wt%) Then, the solution was stirred at room temperature for 8 hours to produce a solution of 18 〇〇CpS of poly-araminic acid at 23 C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Comparative Example 1&gt; 5 As in Example 1, 5.1846 g (0.01 mol) of 4-BDAF was dissolved in 38.5084 g of DMAc, followed by 4.4425 g (0.01 mol) of 6-FDA. 1 hour until 6_FDA is completely dissolved. The solid content of the solution is 20 weight percent (wt%). Then The solution was stirred at room temperature for 8 hours to give a polyamine solvent solution having a viscosity of 1300 cps 10 (hereinafter, a polyimide film was produced in the same manner as in Example 1 and obtained. The film thicknesses were 25 μm, 50 μm and 1 分别, respectively. &lt;Comparative Example 2&gt; As in Example 1 '2.9233 g (0.01 mol) of ΑΡΒ-133 溶 15 solution in 29.482 g of DMAc, followed by 4.4425 Gram (0.01 mol) of 6-FDA was added. The solution was stirred for 1 hour until the 6_FDA was completely dissolved. The solid content of the solution was 20 weight percent (wt%). Then, the solution was stirred at room temperature for 8 hours. A polyamic acid solution having a viscosity of 1200 cps was produced at 23 ° C. 20 Thereafter, a polyimide film was produced in the same manner as in Comparative Example 1. &lt;Comparative Example 3&gt; As Example 1 '2.4830 g (0.01 The 3D DDS of Mohr was dissolved in 27.702 g of DMAc, followed by 4.4425 g of 6-FDA. The solution was stirred for 1 hour until 6_FDA was completely dissolved. 23 1376394 The solid content of the solution was 2 〇 Fan τ, will dissolve under the pieces _ mix for 8 hours, ^ ^ ratio (Wt%), #: After 'at a room temperature strip of poly-araminic acid solution. At 23 C, the viscosity of 1300 cps 1 square polyalkylene amine film. As an example, 2.4830 g of rnm is used in 27.7 〇 2 g of DMAct technology (Mohr) 4_DDS is dissolved ίο 6 times. The solution _ f: T5 g (〇.〇if:) solution has a solid content of 2G. Weight 100, to 6_FDA&quot; ° full 'gluten. Under the pieces will dissolve for 8 hours, New's at room temperature strip of poly-broncine solution. Produced at 23 C, the viscosity is ah, then used The polyimide film was produced in the same manner as in Example 1. <Comparative Example 5> As in the example, 2.0024 g (〇.〇1 mole) of 3,3,-〇da is dissolved in DMAc of 25.7796 g. Then, 4 4425 g (〇〇1 mol) of 6-FDA was added, and the obtained solution was stirred for 1 hour until 6_fda; completely dissolved. The solid content of the solution was 20 weight percent (wt%). Then, The solution was scrambled for 8 hours at room temperature to produce a poly-aracine solution having a viscosity of 1600 cps at 23 ° C. 20 Thereafter, a polyimide film was produced in the same manner as in Comparative Example 1. &lt;Comparative Example 6&gt;

如同範例1,2.0024克(〇.〇1莫耳)的4,4,-〇DA係溶 解於16.7344克的DMAc中,接著將2.1812克(〇.〇1莫耳) 的PMDA加入,並將獲得的溶液授拌1小時,直到PMDA 24 1376394 完全溶解。溶液的固體含量為20重量百分比(wt%)。然後’ 在室溫條件下將溶液攪拌8小時,以產生於23°C時,黏度 為2500 p〇ise的聚醯胺酸溶液。 其後’採用如同比較範例1的方式製造聚亞醯胺膜。 5 上述各範例及比較範例所製得之聚亞酿胺膜的性質, 均依下列方式所測量。結果統整於下列表1至表4。 (1) 透光率及50%截止波長 使用紫外光分光光度計(瓦里安科技股份有限公司, Varian ;型號Cary 100 ),來測量各聚亞酿胺膜的可見光透光 10率及50%截止波長。 將膜厚為50 μιη之範例1及比較範例6的聚亞醯胺膜, 分別置於一張印有黃色文字與線條的紙上,之後拍照。結 果顯示於第一圖及第二圖。 (2) 黃色指數 15 依照ASTME313標準來測量黃色指數。 (3) 光學密度(OD,optical density) 光學密度係依據下列方程式1予以計算: 方程式1 = log ι〇Γ [ log l0(~?·)] 其中/是膜的厚度,4是在波長為χ時的吸光度,f是 透光率’ 是入射光強度,以及/則是透射光強度。 (4) 模數 使用英特斯朗公司(Instron)的萬能試驗機(universai 25 1376394As in Example 1, 2.0024 g (〇.〇1 mol) of 4,4,-〇DA was dissolved in 16.7344 g of DMAc, followed by 2.1812 g (〇.〇1 mol) of PMDA, and will be obtained The solution was mixed for 1 hour until PMDA 24 1376394 was completely dissolved. The solid content of the solution was 20 weight percent (wt%). Then, the solution was stirred at room temperature for 8 hours to give a polyaminic acid solution having a viscosity of 2500 p〇ise at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Comparative Example 1. 5 The properties of the polyacrylamide membranes prepared by the above examples and comparative examples were measured in the following manner. The results are summarized in Tables 1 through 4 below. (1) Light transmittance and 50% cut-off wavelength The ultraviolet light spectrophotometer (Varian Technology Co., Ltd., Varian; model Cary 100) was used to measure the visible light transmittance rate and 50% of each polyacrylamide film. Cutoff wavelength. The polyimide film of Example 1 and Comparative Example 6 having a film thickness of 50 μm was placed on a sheet of paper printed with yellow characters and lines, and photographed. The results are shown in the first and second figures. (2) Yellow index 15 The yellow index is measured in accordance with the ASTM E313 standard. (3) Optical density (OD) The optical density is calculated according to the following equation 1: Equation 1 = log ι〇Γ [ log l0(~?·)] where / is the thickness of the film, and 4 is at the wavelength χ The absorbance at the time, f is the light transmittance 'is the incident light intensity, and / is the transmitted light intensity. (4) Modulus Using Instron's universal testing machine (universai 25 1376394)

Testing Machine),型號 Model 1000,依照 JIS K 6301 標準 來測量模數。 (5) 玻璃轉移溫度(Tg) 使用掃描式熱差分析儀(DSC,ΤΑ儀器,型號Q200), 5 來測量玻璃轉移溫度。 (6) 熱膨脹係數(CTE) 使用熱機械分析儀(ΤΜΑ,ΤΑ儀器,型號Q400),依 照熱機械分析方法(TMA-Method),在50至200°C下測量熱 膨脹係數。 1〇 (7)介電常數 依據ASTMD150來測量介電常數。 【表1】Testing Machine), Model Model 1000, measures the modulus according to JIS K 6301. (5) Glass transition temperature (Tg) The glass transition temperature was measured using a scanning thermal differential analyzer (DSC, ΤΑ instrument, model Q200), 5. (6) Thermal expansion coefficient (CTE) The thermal expansion coefficient was measured at 50 to 200 °C using a thermomechanical analyzer (ΤΜΑ, ΤΑ instrument, model Q400) according to the thermomechanical analysis method (TMA-Method). 1 〇 (7) Dielectric constant The dielectric constant is measured in accordance with ASTM D150. 【Table 1】

組成成分 莫耳比 膜厚 (μιη) 透光率 光學密度 380 nm 至 780 nm 551 nm 至 780 nm 550 nm 500 nm 420 nm 550 nm 500 nm 420 nm 範 例 1 6-FDA+TDA/6-HMDA 7:3:10 50 88.2 90.0 89.8 89.3 60.1 9.34 9.82 44.25 2 6-FDA+TDA/6-HMDA 5:5:10 50 88.0 89.9 89.7 89.3 58.9 9.44 9.83 45.98 3 6-FDA+TDA/6-HMDA 3:7:10 50 87.8 89.5 89.5 88.9 58.0 9.64 10.21 47.31 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 50 86.7 88.5 88.3 87.2 57.7 10.80 11.89 47.76 6 6-FDA+TDA/ 2,2,-TFDB+3-DDS 7:3:7:3 50 88.5 90.3 89.9 89.2 71.5 9.25 9.92 29.14 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 85.6 88.9 88.7 86.4 63.1 10.42 12.70 40.00 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 50 87.3 89.6 89.4 89.0 75.4 9.73 10.12 24.52 26 1376394Composition Moerbi Film Thickness (μιη) Light Transmittance Optical Density 380 nm to 780 nm 551 nm to 780 nm 550 nm 500 nm 420 nm 550 nm 500 nm 420 nm Example 1 6-FDA+TDA/6-HMDA 7: 3:10 50 88.2 90.0 89.8 89.3 60.1 9.34 9.82 44.25 2 6-FDA+TDA/6-HMDA 5:5:10 50 88.0 89.9 89.7 89.3 58.9 9.44 9.83 45.98 3 6-FDA+TDA/6-HMDA 3:7: 10 50 87.8 89.5 89.5 88.9 58.0 9.64 10.21 47.31 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 5 6-FDA+TDA/ 6-HMDA +4-DDS 7:3:7:3 50 86.7 88.5 88.3 87.2 57.7 10.80 11.89 47.76 6 6-FDA+TDA/ 2,2,-TFDB+3-DDS 7:3:7:3 50 88.5 90.3 89.9 89.2 71.5 9.25 9.92 29.14 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 85.6 88.9 88.7 86.4 63.1 10.42 12.70 40.00 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 10 6-FDA +TDA/ APB-133+3-DDS 7:3:7:3 50 87.3 89.6 89.4 89.0 75.4 9.73 10.12 24.52 26 1376394

11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 50 86.8 88.9 88.7 88.2 75.8 10.42 10.91 24.07 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 50 86.7 89.1 88.9 87.3 72.7 10.21 11.79 27.69 13 6-HBDA+TDA/4-DDS 7:3:10 50 87.1 89.5 89.1 87.6 74.6 10.02 11.50 25.5 14 6-HBDA+TDA;4-BDAF 7:3:10 50 86.6 89.2 89.0 87.2 72.9 10.12 11.89 27.45 15 6-HBDA+TDA/ 2,2’-TFDB+4-DDS 7:3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 17 6-HBDA+TDA/ 2,2’-TFDB+3-BDAF 7:3:7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 範 例 1 6-FDA+TDA/6-HMDA 7:3:10 100 87.6 89.6 89.1 87.6 56.2 5.01 5.74 25.02 2 6-FDA+TDA/6-HMDA 5:5:10 100 87.4 89.5 89.0 87.7 54.5 5.06 5.70 26.36 3 6-FDA+TDA/6-HMDA 3:7:10 100 87.2 89.1 88.8 87.5 53.6 5.16 5.80 27.08 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 86.0 88.2 88.2 86.2 53.0 5.45 6.44 27.57 6 6-FDA+TDA/ 2,2’-TFDB+3-DDS 7:3:7:3 100 87.8 89.9 89.4 88.0 67.8 4.87 5.55 16.88 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 100 85.1 88.3 88.2 85.5 59.8 5.45 6.80 22.33 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 100 86.8 89.9 89.8 87.5 70.1 4.67 5.79 15.42 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 100 86.0 88.7 88.3 86.7 70.3 5.40 6.20 15.30 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 100 85.8 88.7 88.3 85.7 68.4 5.40 6.70 16.49 13 6-HBDA+TDA/ 4-DDS 7:3:10 100 86.5 89.2 88.6 86.0 70.2 5.26 6.55 15.37 14 6-HBDA+TDA/ 4-BDAF 7:3:10 100 86.0 88.8 88.4 85.8 68.8 5.35 6.65 16.24 15 6-HBDA+TDA/ 2,2’-TFDB+4-DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 17 6-HBDA+TDA/ 2,2’-TFDB+3-BDAF 7:3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 27 1376394 【表2】11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 50 86.8 88.9 88.7 88.2 75.8 10.42 10.91 24.07 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 50 86.7 89.1 88.9 87.3 72.7 10.21 11.79 27.69 13 6-HBDA+TDA/4-DDS 7:3:10 50 87.1 89.5 89.1 87.6 74.6 10.02 11.50 25.5 14 6-HBDA+TDA; 4-BDAF 7:3:10 50 86.6 89.2 89.0 87.2 72.9 10.12 11.89 27.45 15 6-HBDA+TDA/ 2,2'-TFDB+4-DDS 7:3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 16 6-HBDA+TDA/ 3-BDAF+4 -DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 17 6-HBDA+TDA/ 2,2'-TFDB+3-BDAF 7:3:7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 Example 1 6-FDA+TDA/6-HMDA 7:3:10 100 87.6 89.6 89.1 87.6 56.2 5.01 5.74 25.02 2 6-FDA+TDA/6-HMDA 5:5:10 100 87.4 89.5 89.0 87.7 54.5 5.06 5.70 26.36 3 6-FDA+TDA/6-HMDA 3:7:10 100 87.2 89.1 88.8 87.5 53.6 5.16 5.80 27.08 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 86.0 88.2 88.2 86.2 53.0 5.45 6.44 27.57 6 6-FDA+TDA/ 2,2'-TFDB+3- DDS 7:3:7:3 100 8 7.8 89.9 89.4 88.0 67.8 4.87 5.55 16.88 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 8 6-FDA+TDA/ 4- BDAF+3-DDS 7:3:7:3 100 85.1 88.3 88.2 85.5 59.8 5.45 6.80 22.33 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 100 86.8 89.9 89.8 87.5 70.1 4.67 5.79 15.42 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7 :3 100 86.0 88.7 88.3 86.7 70.3 5.40 6.20 15.30 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 100 85.8 88.7 88.3 85.7 68.4 5.40 6.70 16.49 13 6-HBDA+TDA/ 4-DDS 7: 3:10 100 86.5 89.2 88.6 86.0 70.2 5.26 6.55 15.37 14 6-HBDA+TDA/ 4-BDAF 7:3:10 100 86.0 88.8 88.4 85.8 68.8 5.35 6.65 16.24 15 6-HBDA+TDA/ 2,2'-TFDB+ 4-DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 17 6-HBDA+TDA/ 2,2'-TFDB+3-BDAF 7:3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 27 1376394 [Table 2]

透光率 光學密度 組成成分 莫耳比 膜厚 (μπι) 380 nm 至 551 nm 至 550 500 420 550 500 420 780 nm 780 nm IIIU mil Illll mil liill 1 6-FDA/4-BDAF 10:10 25 82.8 90.0 87.2 86.0 63.1 23.79 26.20 79.98 比 2 6-FDA/APB-133 10:10 25 84.4 89.3 87.8 86.0 77.3 22.60 26.20 44.72 較 3 6-FDA/3-DDS 10:10 25 84.3 88.6 89.7 88.6 66.5 18.88 21.02 70.87 範 4 6-FDA/4-DDS 10:10 25 84.6 89.4 90.5 90.0 72.5 17.34 18.30 55.86 例 5 6-FDA/3,3,-ODA 10:10 25 84.9 89.8 90.0 87.6 77.1 18.30 22.99 45.17 6 PMDA/ODA 10:10 25 56.6 85.2 73.0 35.0 0.05 54.67 182.37 1320 1 6-FDA/4-BDAF 10:10 50 82.2 89.7 86.8 85.1 60.0 12.29 14.01 44.36 比 2 6-FDA/APB-133 10:10 50 83.8 88.8 87.2 84.8 73.2 11.89 14.32 27.09 較 3 6-FDA/3-DDS 10:10 50 83.7 88.2 89.1 87.6 63.1 10.02 11.49 39.99 範 4 6-FDA/4-DDS 10:10 50 83.9 89.1 90.0 89.1 69.4 9.15 10.02 31.72 例 5 6-FDA/3,3,-ODA 10:10 50 84.3 89.3 89.2 86.3 73.8 9.92 12.79 26.38 6 PMDA/ODA ΓΊό:ι〇 50 56.0 84.5 69.2 33.1 0 31.97 96.03 1 6-FDA/4-BDAF 10:10 100 81.6 89.2 86.3 84.3 51.2 6.39 7.41 29.07 比 2 6-FDA/APB-133 10:10 100 83.1 88.1 86.7 84.3 63.3 6.19 7.41 19.85 較 3 6-FDA/3-DDS 10:10 100 83.1 87.8 88.5 87.0 53.5 5.30 6.04 27.16 範 4 6-FDA/4-DDS 10:10 100 83.2 88.8 89.5 88.6 58.6 4.81 5.25 23.21 例 5 6-FDA/3,3,-ODA 10:10 100 83.5 88.7 88.8 85.4 62.1 5.15 6.85 20.69 6 PMDA/ODA 10:10 100 - • 1 - - - 【表3】 組成成分 莫耳比 膜厚 (μιη) 黃色 指數 50%截止 波長(nm) 模數 (GPa) Tg (°C) CTE (ppm/°C) 介電常數 /1GHz 範 i 6-FDA+TDA/6-HMDA 7:3:10 50 3.45 386 3.50 245 40 2.77 例 2 6-FDA+TDA/6-HMDA 5:5:l〇 50 3.49 386 3.42 240 42 2.79 J 6-FDA+TDA/6-HMDA 3:7:10 50 3.51 386 3.51 226 44 2.85 4 6-FDA+TDA/ 6-HMDA 十 3-DDS 7:3:7:3 50 3.86 388 3.34 265 46 2.9 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 50 3.85 384 3.38 271 45 2.96 6 6-FDA+TDA/ 2,2,-TFDB+3-DDS 7:3:7:3 50 1.86 380 3.04 245 46 2.8 7 6-FDA+TDA/ 2,2’-TFDB+4-DDS 7:3:7:3 50 2.45 384 3.02 247 44 2.86 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 6.7 394 3.05 234 48.8 2.60 28 1376394 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.09 241 47.9 2.61 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 50 4.6 388 3.0 212 46.7 2.70 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 50 4.4 396 3.0 260 46.4 2.70 12 6-HBDA+TDA/ 2,2’-TFDB 7:3:10 50 2.87 386 3.26 236 47 2.78 13 6-HBDA+TDA/4-DDS 7:3:10 50 4.08 386 3.07 225 48 2.74 14 6-HBDA+TDA/4-BDAF 7:3:10 50 7.67 389 3.12 241 46 2.59 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 50 2.45 384 3.12 220 45 2.86 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.05 231 47 2.61 17 6-HBDA+TDA/ 2,25-TFDB+3-BDAF 7:3:7:3 50 3.86 388 3.06 218 46 2.9 範 例 1 6-FDA+TDA/6-HMDA 7:3:10 100 4.12 389 3.52 - 38 - 2 6-FDA+TDA/6-HMDA 5:5:10 100 4.13 389 3.46 - 39 - 3 6-FDA+TDA/6-HMDA 3:7:10 100 4.15 388 3.48 - 41 - 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 100 4.76 390 3.39 - 42 - 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 4.73 388 3.41 - 41 - 6 6-FDA+TDA/ 2,2’-TFDB+3-DDS 7:3:7:3 100 2.83 385 3.12 45 - 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.1 - 43 - 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 100 7.5 397 3.09 - 47.9 - 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 7.5 396 3.14 - 47.1 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 100 5.8 393 3.12 46.0 - 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 100 5.7 398 3.17 - 45.6 - 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 100 3.67 388 3.31 - 46 13 6-HBDA+TDA/4-DDS 7:3:10 100 5.12 389 3.13 - 47 - 14 6-HBDA+TDA/4-BDAF 7:3:10 100 8.47 391 3.21 - 46 - 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.18 - 43.7 - 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 100 7.5 396 3.12 - 46.7 - 17 6-HBDA+TDA/ 2,2’-TFDB+3-BDAF 7:3:7:3 100 4.76 390 3.12 - 45.5 - 29 1376394 【表4】 1376394Light transmittance Optical density Composition Mohby film thickness (μπι) 380 nm to 551 nm to 550 500 420 550 500 420 780 nm 780 nm IIIU mil Illll mil liill 1 6-FDA/4-BDAF 10:10 25 82.8 90.0 87.2 86.0 63.1 23.79 26.20 79.98 Ratio 2 6-FDA/APB-133 10:10 25 84.4 89.3 87.8 86.0 77.3 22.60 26.20 44.72 Compared with 3 6-FDA/3-DDS 10:10 25 84.3 88.6 89.7 88.6 66.5 18.88 21.02 70.87 6-FDA/4-DDS 10:10 25 84.6 89.4 90.5 90.0 72.5 17.34 18.30 55.86 Example 5 6-FDA/3,3,-ODA 10:10 25 84.9 89.8 90.0 87.6 77.1 18.30 22.99 45.17 6 PMDA/ODA 10:10 25 56.6 85.2 73.0 35.0 0.05 54.67 182.37 1320 1 6-FDA/4-BDAF 10:10 50 82.2 89.7 86.8 85.1 60.0 12.29 14.01 44.36 Ratio 2 6-FDA/APB-133 10:10 50 83.8 88.8 87.2 84.8 73.2 11.89 14.32 27.09 3 6-FDA/3-DDS 10:10 50 83.7 88.2 89.1 87.6 63.1 10.02 11.49 39.99 Fan 4 6-FDA/4-DDS 10:10 50 83.9 89.1 90.0 89.1 69.4 9.15 10.02 31.72 Example 5 6-FDA/3, 3,-ODA 10:10 50 84.3 89.3 89.2 86.3 73.8 9.92 12.79 26.38 6 PMDA/ODA ΓΊό:ι〇50 56.0 84.5 69.2 33.1 0 31.97 9 6.03 1 6-FDA/4-BDAF 10:10 100 81.6 89.2 86.3 84.3 51.2 6.39 7.41 29.07 Ratio 2 6-FDA/APB-133 10:10 100 83.1 88.1 86.7 84.3 63.3 6.19 7.41 19.85 More than 3 6-FDA/3- DDS 10:10 100 83.1 87.8 88.5 87.0 53.5 5.30 6.04 27.16 Fan 4 6-FDA/4-DDS 10:10 100 83.2 88.8 89.5 88.6 58.6 4.81 5.25 23.21 Example 5 6-FDA/3,3,-ODA 10:10 100 83.5 88.7 88.8 85.4 62.1 5.15 6.85 20.69 6 PMDA/ODA 10:10 100 - • 1 - - - [Table 3] Composition Mohby Film Thickness (μιη) Yellow Index 50% Cutoff Wavelength (nm) Modulus (GPa) Tg (°C) CTE (ppm/°C) Dielectric constant / 1 GHz Fan i 6-FDA+TDA/6-HMDA 7:3:10 50 3.45 386 3.50 245 40 2.77 Example 2 6-FDA+TDA/6- HMDA 5:5:l〇50 3.49 386 3.42 240 42 2.79 J 6-FDA+TDA/6-HMDA 3:7:10 50 3.51 386 3.51 226 44 2.85 4 6-FDA+TDA/ 6-HMDA X3-DDS 7:3:7:3 50 3.86 388 3.34 265 46 2.9 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 50 3.85 384 3.38 271 45 2.96 6 6-FDA+TDA/ 2 , 2,-TFDB+3-DDS 7:3:7:3 50 1.86 380 3.04 245 46 2.8 7 6-FDA+TDA/ 2,2'-TFDB+4-DDS 7:3:7:3 50 2.45 384 3.02 247 44 2.86 8 6- FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 6.7 394 3.05 234 48.8 2.60 28 1376394 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.09 241 47.9 2.61 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 50 4.6 388 3.0 212 46.7 2.70 11 6-FDA+TDA/ APB-133+4-DDS 7:3 :7:3 50 4.4 396 3.0 260 46.4 2.70 12 6-HBDA+TDA/ 2,2'-TFDB 7:3:10 50 2.87 386 3.26 236 47 2.78 13 6-HBDA+TDA/4-DDS 7:3: 10 50 4.08 386 3.07 225 48 2.74 14 6-HBDA+TDA/4-BDAF 7:3:10 50 7.67 389 3.12 241 46 2.59 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3 :7:3 50 2.45 384 3.12 220 45 2.86 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.05 231 47 2.61 17 6-HBDA+TDA/ 2,25- TFDB+3-BDAF 7:3:7:3 50 3.86 388 3.06 218 46 2.9 Example 1 6-FDA+TDA/6-HMDA 7:3:10 100 4.12 389 3.52 - 38 - 2 6-FDA+TDA/6 -HMDA 5:5:10 100 4.13 389 3.46 - 39 - 3 6-FDA+TDA/6-HMDA 3:7:10 100 4.15 388 3.48 - 41 - 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 100 4.76 390 3.39 - 42 - 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 4.73 388 3.41 - 41 - 6 6-FDA+TDA/ 2 , 2'-TFDB+3-DDS 7:3:7:3 100 2.83 385 3.12 45 - 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.1 - 43 - 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7 :3 100 7.5 397 3.09 - 47.9 - 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 7.5 396 3.14 - 47.1 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 100 5.8 393 3.12 46.0 - 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 100 5.7 398 3.17 - 45.6 - 12 6-HBDA+TDA/ 2, 2,-TFDB 7:3:10 100 3.67 388 3.31 - 46 13 6-HBDA+TDA/4-DDS 7:3:10 100 5.12 389 3.13 - 47 - 14 6-HBDA+TDA/4-BDAF 7:3 :10 100 8.47 391 3.21 - 46 - 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.18 - 43.7 - 16 6-HBDA+TDA/ 3-BDAF +4-DDS 7:3:7:3 100 7.5 396 3.12 - 46.7 - 17 6-HBDA+TDA/ 2,2'-TFDB+3-BDAF 7:3:7:3 100 4.76 390 3.12 - 45.5 - 29 1376394 [Table 4] 1376394

組成成分 莫耳比 膜厚 (μιη) 黃色 指數 50% 截止波長 (nm) 模數 (GPa) Tg (°C) CTE (Ppm/°C) 介電常數 /1GHz 比 較 範 例 1 6-FDA/4-BDAF 10:10 25 9.7 411 3.0 263 52 1 2 6-FDA/APB-133 10:10 25 5.5 395 3.05 206 47 1 2 7 3 6-FDA73-DDS 10:10 25 1.82 388 3.1 270 47 3 0 4 6-FDA/4-DDS 10:10 25 1.68 382 3.1 310 46 3 1 b-FlJA/3,3 ,_OL)A 10:10 25 5.29 396 3.0 244 41 2.73 6 PMDA/ODA 10:10 25 91.7 514 3.0 No 26 3 3 比 較 範 例 1 6-FDA/4-BDAF 10:10 50 11.2 413 3.06 51 1 2 6-FDA/APB-133 10:10 50 6.9 398 3.11 46 Π 3 6-FDA/3-DDS 10:10 50 2.95 392 3.16 45 ·3 4 6-FDA/4-DDS 10:10 50 2.81 386 3.17 • 45 1 5 6_FDA/3,3,-ODA 10:10 50 6.46 399 3.05 fi 6 PMDA/ODA 10:10 50 - - 3.12 • ,Ό 25 〇 比 較 範 例 1 6-FDA/4-BDAF 10:10 Ιϋϋ 23.4 415 Γ3.09 _ 4g « 2 6-FDA/APB-133 10:10 Ιϋϋ ΓΤ4.2 401 3.14 44 5 3 10:10 100 4.54 396 3.20 44 〇 4 6-FDA/4-DDS 10:10 100 4.26 390 3.22 鱗 446 5 6-FDA/3,3’-ODA 10:10 100 14.26 405 3.13 30 1 6 PMDA/ODA 10:10 100 • - ~-— 厚為50 μιη及100 μπι的聚亞醯胺膜,於波長38〇至78〇 ^ 時的平均透光率等於或大於85% ’黃色指數等於或小於 15,以及於波長420 nm時的光學密度等於或小於5(^如第 -圖所示,符合前述透光率、黃色純與光學密度的聚亞 醯胺膜,係透明到可使置於其下方之紙張上所印的黃色 字與線條,均能被看到的程度。 、 在比較範例中,無論其薄膜厚度為何,沒有任何 1〇例子在可見光範圍波長380至780 nm時的平均透光率等於 或大於85%。此外,在比較範例6中,無法製出膜厚等於 30 1376394 或大於90 μηι的聚亞醯胺膜。 在本發明各範例所製造的聚亞_膜 小於働nm時,且有η牡反食等於或 八有50/0的透先率,最终實現一種且有優 -可見光透料的無色透明聚麵賴。因此本發明 亞醯胺膜可用來作為太陽能電池用的表面保護膜。此外, 因為聚亞醯胺膜的平均熱膨脹係數等於或小於5〇ppm’所 以月b展現尚度的尺寸穩定性,並且,由於其模數等於咬大 於3.0 GPa,因而顯現出應用於捲壓(Ron to R〇u)製程所需 的薄膜性質《再者,本發明的聚亞醯胺膜還可應用於製造 軟性顯示器基板與活動顯示器所用的TFT製程,並且,該 膜具有等於或小於3.0的介電常數,是以能用來作為半導體 鈍化膜。Composition Mohrby Film Thickness (μιη) Yellow Index 50% Cutoff Wavelength (nm) Modulus (GPa) Tg (°C) CTE (Ppm/°C) Dielectric Constant / 1 GHz Comparative Example 1 6-FDA/4- BDAF 10:10 25 9.7 411 3.0 263 52 1 2 6-FDA/APB-133 10:10 25 5.5 395 3.05 206 47 1 2 7 3 6-FDA73-DDS 10:10 25 1.82 388 3.1 270 47 3 0 4 6 -FDA/4-DDS 10:10 25 1.68 382 3.1 310 46 3 1 b-FlJA/3,3 ,_OL)A 10:10 25 5.29 396 3.0 244 41 2.73 6 PMDA/ODA 10:10 25 91.7 514 3.0 No 26 3 3 Comparative Example 1 6-FDA/4-BDAF 10:10 50 11.2 413 3.06 51 1 2 6-FDA/APB-133 10:10 50 6.9 398 3.11 46 Π 3 6-FDA/3-DDS 10:10 50 2.95 392 3.16 45 ·3 4 6-FDA/4-DDS 10:10 50 2.81 386 3.17 • 45 1 5 6_FDA/3,3,-ODA 10:10 50 6.46 399 3.05 fi 6 PMDA/ODA 10:10 50 - - 3.12 • , Ό 25 〇 Comparative example 1 6-FDA/4-BDAF 10:10 Ιϋϋ 23.4 415 Γ3.09 _ 4g « 2 6-FDA/APB-133 10:10 Ιϋϋ ΓΤ4.2 401 3.14 44 5 3 10:10 100 4.54 396 3.20 44 〇4 6-FDA/4-DDS 10:10 100 4.26 390 3.22 Scale 446 5 6-FDA/3, 3'-ODA 10:10 100 14.26 405 3.13 30 1 6 PMDA/ODA 10:10 100 • - ~-— Polyimide film with a thickness of 50 μm and 100 μm, with an average light transmittance of 85% or more at a wavelength of 38 〇 to 78 ' 'Yellow index equals or Less than 15, and the optical density at a wavelength of 420 nm is equal to or less than 5 (as shown in the first figure, the polyimide film conforming to the aforementioned light transmittance, yellow pure and optical density, is transparent to enable placement The yellow words and lines printed on the paper below it can be seen. In the comparative example, regardless of the film thickness, there is no case where the average light transmittance at the wavelength of 380 to 780 nm in the visible light range is equal to or greater than 85%. Further, in Comparative Example 6, a polyimide film having a film thickness equal to 30 1376394 or more than 90 μm was not produced. When the poly-sub-film produced by the examples of the present invention is smaller than 働nm, and there is a opacity of η 反 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 Lai. Therefore, the melamine film of the present invention can be used as a surface protective film for solar cells. In addition, since the average thermal expansion coefficient of the polyimide film is equal to or less than 5 〇 ppm', the monthly b exhibits dimensional stability of the degree, and since it has a modulus equal to a bite of more than 3.0 GPa, it appears to be applied to the crimping ( Ron to R〇u) Film properties required for the process. Further, the polyimide film of the present invention can also be applied to a TFT process for manufacturing a flexible display substrate and a movable display, and the film has a ratio of 3.0 or less. The dielectric constant can be used as a semiconductor passivation film.

31 1376394 【圖式簡單說明】 第一圖係為範例1之聚亞醯胺膜置於一張紙上的照 片;以及 第二圖係為比較範例1之聚亞醯胺膜置於一張紙上的 5照片。31 1376394 [Simple description of the drawings] The first picture is a photograph of the polyimide film of Example 1 placed on a piece of paper; and the second picture is the film of the polyimide film of Comparative Example 1 placed on a piece of paper. 5 photos.

3232

Claims (1)

1376394 ► iQ1年G1月%日修正替換頁 ^ 十、申請專利範圍: ~ ^— 1. -種聚魏胺膜’係由芳香族二酸賴芳香族 ' 之聚合物所製成,在該膜厚度為50至1〇〇 μιη的基準;, 使用紫外光分光光度計測量其透光率,於波長38〇至MO nm時,該膜具有等於或大於85%的平均透光率,並且,誃 5膜的黃色指數等於或小於15 ; 其巾該芳香族二㈣包括選自下列所構成之族群的二 種或多種化合物的混合物:2,2-雙(3,4-二羧基笨基)六氟 • 丙烷二酸酐(6_FDA)、4-(2,5-二氧四氫呋喃-3-基) 四氫化萘-l,2-二羧酸酐(TDA)、以及4,4,—(4,4、異丙婦’基 ίο二苯氧基)雙(鄰苯二甲酸酐)(HBDA);以及 該芳香族二胺包括選自下列所構成之族群的一種化合 物,或是二種或多種化合物的混合物:氧化二苯胺(〇DA)、 1,3-雙(3-胺基笨氧基)苯(APB_133)、丨,3_雙(4_胺基笨 氧基)笨(APB-134)、1,4-雙(4-胺基苯氧基)苯(APB_144)、 15雙(3-胺基苯基);ε風(3-DDS)、雙(4-胺基苯基)砜(4-DDS)、 φ 2,2’-雙(三氟甲基)-4,4’-二胺基聯苯(2,2,-TFDB)、3,3,-雙(三氟曱基)-4,4,-二胺基聯苯(3,3,-TFDB)、2,2,-雙[4 (4-胺基苯氧基)苯基]六氟丙烷(4_]81)八17)、2,2,_雙[3(3— 胺基苯氧基)苯基]六氟丙烷(3_BDAF)、4,4,-雙(3-胺基苯 -2〇氧基)二苯基颯(DBSDA)、以及2,2-雙[4_(4-胺基苯氧基) 笨基]丙烧(6-HMDA)。 2.如申請專利範圍第1項所述之聚亞醯胺膜,在該膜 厚度為50至1〇〇 的基準下,使用紫外光分光光度計測 量其透光率,於波長551至780 nm時,該膜具有等於或大 33 13763941376394 ► iQ1 year G1 month % correction replacement page ^ X. Patent application scope: ~ ^— 1. - Polyurethane film 'made of a polymer of aromatic diacid lysine' in the film a reference having a thickness of 50 to 1 〇〇μηη; measuring the light transmittance thereof using an ultraviolet spectrophotometer, the film having an average transmittance of 85% or more at a wavelength of 38 〇 to MO nm, and 誃5 The yellow index of the film is equal to or less than 15; the aromatic di(tetra) of the film comprises a mixture of two or more compounds selected from the group consisting of 2,2-bis(3,4-dicarboxyphenyl)hexa Fluorine-propane dianhydride (6_FDA), 4-(2,5-dioxotetrahydrofuran-3-yl)tetralin-l,2-dicarboxylic anhydride (TDA), and 4,4,-(4,4, Isopropyl 'glycolyldiphenoxy) bis(phthalic anhydride) (HBDA); and the aromatic diamine comprises a compound selected from the group consisting of the following, or a mixture of two or more compounds : Diphenylamine (〇DA), 1,3-bis(3-aminophenyloxy)benzene (APB_133), hydrazine, 3_bis(4-aminophenyloxy) stupid (APB-134), 1 4-bis(4-aminophenoxy)benzene (APB_144), 15 bis(3-aminophenyl); ε wind (3-DDS), bis(4-aminophenyl)sulfone (4-DDS) ), φ 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl (2,2,-TFDB), 3,3,-bis(trifluoromethyl)-4, 4,-Diaminobiphenyl (3,3,-TFDB), 2,2,-bis[4 (4-aminophenoxy)phenyl]hexafluoropropane (4_]81) VIII 17), 2 , 2,_bis[3(3-aminophenoxy)phenyl]hexafluoropropane (3_BDAF), 4,4,-bis(3-aminophenyl-2-decyloxy)diphenylanthracene (DBSDA) And 2,2-bis[4_(4-aminophenoxy)phenyl]propane (6-HMDA). 2. The polyamidamine film according to claim 1, wherein the transmittance is measured by an ultraviolet spectrophotometer at a wavelength of 50 to 1 Torr, at a wavelength of 551 to 780 nm. When the film has equal or large 33 1376394 101年01月〆日修正替換頁Corrected replacement page on January 30, 101 於88/。的平均透光率,於波長55〇nm肖該膜具有等於或 大於88%的透光率,於波長500 nm時,該膜具有等於或大 於85/〇的透光率’以及於波長42〇nm時,該膜具有等於或 大於50%的透光率。 5 β 3.如申請專利範圍第1項所述之聚魏賴,在該膜 厚度為50至1〇〇 μιη的基準下,於波長42〇 nm時, 有小於50的光學密度。 、八 4.如申請專利朗第1項所述之聚魏胺膜,在該膜 厚度為50至100卿的基準下,該膜於1 GHz時具有等於 10或小於3.0的介電常數0 5.如申請補範圍第1項所述之聚亞醯賴,在該膜 厚度為50至1〇〇 μιη的基準下,該膜於5〇至2〇〇(&gt;c的溫度 下,具有等於或小於50 ppm的平均熱膨脹係數。 6·如申請專利範圍第丨項所述之聚亞醯胺膜,在該膜 b厚度為50至100 μιη的基準下,該膜具有等於或大於丄〇 GPa的模數。 7.如申請專利範圍第1項所述之聚亞醯胺膜,在該膜 f度為50至100 μιη的基準下,使用紫外光分光光度計測 畺其透光率,該膜具有等於或小於4〇〇 nm之5〇。/。截止波長 ,2〇 (cut off wavelength)。 . 8. 一種顯示器用基板,包含申請專利範圍第1到第7 項中任一項所述的聚亞醯胺膜。 34At 88/. The average light transmittance is such that the film has a light transmittance equal to or greater than 88% at a wavelength of 55 Å, and the film has a light transmittance equal to or greater than 85 Å at a wavelength of 500 nm and a wavelength of 42 〇. At nm, the film has a light transmittance equal to or greater than 50%. 5 β 3. The polyweilai according to the first aspect of the patent application has an optical density of less than 50 at a wavelength of 42 〇 nm on the basis of a film thickness of 50 to 1 μm. 8. The poly-weimin film according to claim 1, wherein the film has a dielectric constant of 10 or less at 1 GHz on a basis of a film thickness of 50 to 100 qing. The polyaluminum yam according to claim 1, wherein the film has a temperature of 5 Torr to 2 Torr (&gt;c at a temperature of 50 to 1 〇〇μηη) Or an average coefficient of thermal expansion of less than 50 ppm. 6. The polyamidamine film according to the above-mentioned claim, wherein the film has a thickness equal to or greater than 丄〇GPa on the basis of a thickness of the film b of 50 to 100 μm. 7. The polyimin film according to claim 1, wherein the film is measured by an ultraviolet spectrophotometer under the reference of 50 to 100 μm of the film, the film Having a 等于 等于 等于 等于 等于 等于 等于 等于 具有 具有 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. 8. Polyimide film. 34
TW96148315A 2006-12-15 2007-12-17 Polyimide film TWI376394B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR1020060128999A KR101167339B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060129011A KR101167483B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060128978A KR101167337B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060129005A KR101142692B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060128992A KR101211857B1 (en) 2006-12-15 2006-12-15 Colorless polyimide film
KR1020060129009A KR101167341B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same

Publications (2)

Publication Number Publication Date
TW200900431A TW200900431A (en) 2009-01-01
TWI376394B true TWI376394B (en) 2012-11-11

Family

ID=39511885

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96148315A TWI376394B (en) 2006-12-15 2007-12-17 Polyimide film

Country Status (2)

Country Link
TW (1) TWI376394B (en)
WO (1) WO2008072916A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101293346B1 (en) * 2008-09-26 2013-08-06 코오롱인더스트리 주식회사 Polyimide film
JP5682956B2 (en) * 2009-02-13 2015-03-11 学校法人東京工芸大学 Image display device and organic electroluminescence element
TWI472555B (en) 2010-12-23 2015-02-11 Ind Tech Res Inst Polyimide polymer, method for manufacturing the same and display device
KR101579645B1 (en) * 2013-04-10 2015-12-22 코오롱인더스트리 주식회사 Polyimide Cover Substrate
JP6615226B2 (en) * 2015-04-28 2019-12-04 コーロン インダストリーズ インク Polyimide resin and film using the same
CN111205643A (en) * 2020-03-20 2020-05-29 无锡创彩光学材料有限公司 Transparent polyimide film and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338826A (en) * 1987-07-15 1994-08-16 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administation Structures from low dielectric polyimides
US5986036A (en) * 1997-06-27 1999-11-16 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Substrate material for holographic emulsions utilizing fluorinated polyimide film
US6232428B1 (en) * 1999-01-19 2001-05-15 I.S.T. Corporation Essentially colorless, transparent polyimide coatings and films
US7247367B2 (en) * 2001-02-23 2007-07-24 Kaneka Corporation Polyimide film and process for producing the same
JP2004006735A (en) * 2002-03-22 2004-01-08 Ube Ind Ltd Polyimide film for insulating inside of semiconductor package and laminated substrate

Also Published As

Publication number Publication date
WO2008072916A1 (en) 2008-06-19
TW200900431A (en) 2009-01-01

Similar Documents

Publication Publication Date Title
TWI376393B (en) Polyimide resin and liquid crystal alignment layer and polyimide film using the same
TWI376392B (en) Polyimide resin and liquid crystal alignment layer and polyimide film using the same
TWI683837B (en) Polyamide-imide precursor composition, polyamide-imide film and display device
JP7304338B2 (en) Method for producing polyimide film and method for producing electronic device
JP5597131B2 (en) Polyimide film
KR101227317B1 (en) Polyimide film with improved thermal stability
JP5295195B2 (en) Colorless and transparent polyimide film with improved solvent resistance
TW200925187A (en) Polyimide film
TWI376394B (en) Polyimide film
TW201827487A (en) Polyamideimide copolymers and colorless and transparent polyamideimide film comprising the same
KR102251518B1 (en) Polyamic acid, And Polyimide Resin And Polyimide Film
KR101225826B1 (en) Colorless polyimide film
KR101292993B1 (en) Polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR101211857B1 (en) Colorless polyimide film
KR101232534B1 (en) Transparent film
TW202043336A (en) Polyamide-imide block copolymers, preparation method thereof and polyamide-imide film comprising the same
KR101142692B1 (en) Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
TW202323391A (en) Polyamideimide precursor composition, method for producing the same, and use thereof